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General	  Introduction	  	   	  
The	  thymus	  is	  located	  superior	  to	  the	  heart	  in	  the	  upper	  anterior	  thorax.	  It	  consists	  of	  two	  lobes,	  which	  can	  be	  further	  subdivided	  into	  cortical	  and	  medullary	  areas	  that	  make	  up	  the	  thymic	  stroma	  and	  have	  distinct	  functions	  in	  T-­‐	  cell	  development	  and	  selection.	  The	  thymus	  arises	  along	  with	  the	  parathyroid	  glad	  from	  the	  endodermal	  gut	  tube,	  in	  particular	  it	  is	  derived	  from	  the	  outpocket	  of	  the	  third	  pharyngeal	  pouch.	  The	  parathyroid	  specific	  molecular	  marker,	  glial	  cells	  missing	  homolong	  2	  (Gcms2)	  is	  first	  expressed	  at	  embryonic	  day	  9.5	  while	  the	  thymus	  specific	  marker	  FoxN1	  (Forkhead	  family	  transcription	  factor),	  which	  is	  essential	  for	  TEC	  proliferation	  and	  differentiation	  beings	  expression	  at	  embryonic	  day	  11.	  Even	  though	  FoxN1	  expression	  is	  essential	  for	  thymic	  development,	  it	  is	  not	  responsible	  for	  lineage	  commitment	  of	  these	  cells.	  Furthermore,	  epithelial-­‐mesencymal	  interactions	  are	  also	  essential	  for	  thymic	  development	  to	  take	  place	  as	  well	  as	  signals	  from	  double	  negative	  thymocytes.	  Hence	  the	  molecular	  mechanisms	  governing	  the	  differentiation	  of	  cTECs	  and	  mTECs	  as	  well	  as	  the	  endodermal	  tissue	  commitment	  to	  become	  the	  thymus	  are	  yet	  to	  be	  defined.	  [120]	  
The	  thymic	  microenvironment	  is	  responsible	  for	  proper	  development	  of	  T	  cells	  from	  multipotent	  hematopoietic	  stem	  cells	  (HSC).	  Committed	  lymphocyte	  progenitors	  [1],	  which	  differentiate	  from	  HSC,	  migrate	  from	  the	  bone	  marrow	  to	  the	  thymus	  where	  they	  undergo	  further	  differentiation	  [2-­‐4]	  and	  selection,	  which	  leads	  to	  presentation	  of	  a	  repertoire	  of	  self-­‐tolerant	  T	  cells	  receptors	  (TCRs)	  on	  the	  T	  cells.	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The	  thymic	  microenvironment	  selects	  for	  self-­‐tolerant	  TCR	  through	  interactions	  with	  cortical	  and	  medullary	  thymic	  epithelial	  cells	  [5].	  	  
Cortical	  thymic	  epithelial	  cells	  (cTECs)	  release	  chemokines	  that	  attract	  the	  T-­‐cells	  precursors	  to	  the	  cortex,	  where	  they	  further	  differentiated	  into	  immature	  double-­‐negative	  thymocytes	  and	  eventually	  leading	  to	  positive	  selection	  of	  double	  positive	  (DP)	  thymocytes	  [6].	  The	  cTECs	  further	  positively	  select	  DP	  thymocytes	  as	  single	  positive	  thymocytes	  by	  exposing	  them	  to	  Major	  Histocompatibility	  complex	  Class	  I	  (MHCI)	  interaction	  with	  CD8-­‐TCR	  or	  MHCII	  interaction	  CD4-­‐TCR	  called	  MHC	  restriction	  [7].	  Medullary	  thymic	  epithelial	  cells	  (mTECs)	  are	  a	  heterogeneous	  population	  of	  cells	  that	  supplementary	  negatively	  select	  the	  SP	  thymocytes	  [7].	  mTECs	  in	  addition	  to	  dendritic	  cells	  present	  peripheral	  antigens	  on	  MHCI	  &	  MHCII	  for	  negative	  selection	  of	  SP	  T	  cells	  that	  are	  reactive	  for	  these	  self	  antigen	  [8-­‐11].	  mTECs	  are	  able	  to	  accomplish	  this	  by	  up-­‐regulating	  Autoimmune	  Regulator	  (AIRE).	  	  
AIRE	  leads	  to	  a	  production	  of	  large	  number	  of	  tissue-­‐specific	  self	  antigens,	  and	  recognition	  of	  self-­‐antigen	  by	  the	  SP	  T-­‐cells	  drives	  the	  process	  of	  negative	  selection	  by	  mTECs	  [12]	  and	  removal	  of	  auto	  reactive	  T-­‐cells	  from	  the	  population.	  The	  correct	  formation	  and	  organization	  of	  the	  thymic	  microenvironment	  is	  crucial	  for	  proper	  T	  cell	  development,	  however	  the	  pattering	  events	  are	  poorly	  understood	  and	  therefore	  no	  clear	  molecular	  mechanisms	  that	  strictly	  control	  this	  process	  has	  been	  clearly	  defined.	  	  
	   Thymic	  involution	  occurs	  with	  age	  and	  results	  in	  a	  progressive	  loss	  of	  the	  thymic	  microenvironment	  that	  leads	  to	  a	  loss	  in	  the	  repertoire	  of	  naive	  T	  cells,	  even	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though	  the	  total	  number	  of	  T	  cells	  in	  the	  periphery	  stays	  the	  same.	  This	  involution	  appears	  to	  occur	  through	  epithelial	  to	  mesenchyme	  transition,	  which	  results	  in	  an	  abundance	  of	  fibroblasts	  that	  eventually	  become	  adipocytes	  [13-­‐15].	  However,	  this	  loss	  of	  thymic	  architecture	  has	  been	  shown	  to	  be	  at	  least	  partially	  reversible.	  Castration	  of	  2	  year	  old	  male	  mice	  resulted	  in	  a	  thymic	  microenvironment	  that	  resembled	  a	  2	  month	  old	  male	  mice.	  This	  reversal	  in	  thymic	  architecture	  also	  correlated	  with	  a	  reversal	  in	  the	  level	  of	  T	  cell	  differentiation,	  proliferation	  and	  apoptosis	  in	  the	  thymus	  [16].	  These	  results	  suggest	  the	  presence	  of	  TEC	  progenitors	  that	  are	  capable	  of	  this	  thymic	  regeneration	  in	  an	  adult	  thymus.	  Hence	  with	  a	  better	  understanding	  of	  the	  mechanisms	  involved	  in	  patterning	  of	  the	  thymus	  together	  with	  the	  capability	  to	  isolated	  TEC	  progenitors,	  one	  could	  attempt	  to	  reconstitute	  the	  thymic	  microenvironment	  in	  vitro	  or	  in	  vivo	  using	  postnatal	  TEC	  progenitors.	  This	  could	  be	  used	  as	  a	  preventative	  measure	  to	  increase	  the	  repertoire	  of	  T	  cells	  in	  aging	  patients	  as	  well	  as	  to	  reconstitute	  a	  functional	  immune	  system	  faster,	  in	  patients	  undergoing	  chemotherapy.	  	  
Even	  though	  there	  are	  systems	  that	  can	  cause	  reconstitution	  of	  the	  thymus	  to	  take	  place	  including	  using,	  Lupron	  which	  is	  an	  androgen	  inhibitor	  and	  acts	  in	  similar	  manner	  as	  castration	  of	  male	  mice,	  FGF-­‐7	  which	  is	  produced	  primarily	  by	  single	  positive	  T-­‐cells	  with	  the	  receptor	  FGF2IIIb	  expression	  predominantly	  on	  TECs,	  as	  well	  as,	  IL-­‐7	  which	  promotes	  lymphocyte	  development,	  all	  current	  approaches	  lead	  to	  only	  a	  transient	  recovery	  of	  the	  thymus[16].	  Hence	  a	  more	  stable	  mechanism	  is	  still	  needed	  to	  reconstitute	  the	  immune	  system.	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Materials	  and	  Methods	  
Ethics	  Statement:	  	  
All	  mice	  used	  in	  this	  study	  were	  bred	  and	  maintained	  at	  the	  City	  College	  of	  New	  York	  animal	  facility	  and	  all	  experiments	  were	  performed	  with	  approval	  from	  the	  City	  College	  of	  New	  York	  Institutional	  Animal	  Care	  and	  Use	  Committee.	  	  The	  animal	  care	  facility	  at	  the	  City	  College	  of	  New	  York	  is	  certified	  at	  both	  the	  State	  and	  Federal	  levels.	  	  The	  CCNY	  animal	  assurance	  number	  is	  A3733-­‐01.	  	  	  
Mice	  
Dr.	  Adam	  Glick	  (Penn	  State	  University)	  generously	  provided	  K5tTA	  mice.	  TetO-­‐H2BGFP	  mice	  have	  been	  previously	  described	  [17-­‐20].	  TetO-­‐H2BGFP,	  Nude,	  and	  C57BL/6JJ	  mice	  were	  obtained	  from	  the	  Jackson	  Laboratory	  (Bar	  Harbor,	  ME).	  Adult	  TetO-­‐H2BGFP;K5tTA	  DT	  and	  litter	  mate	  heterozygous	  control	  animals	  were	  fed	  mouse	  diet	  containing	  doxycycline	  (Dox)	  (2	  g/kg,	  BioServe,	  NJ)	  for	  8	  weeks	  to	  6	  months	  beginning	  at	  4	  weeks	  of	  age,	  unless	  otherwise	  indicated.	  	  
Dr.	  Anna-­‐Katerina	  Hadjantonakis	  (Sloan-­‐Kettering	  Institute)	  generously	  provided	  TCF/LEF-­‐H2BGFP	  mice.	  TCF/LEF-­‐H2BGFP	  mice	  have	  been	  previously	  described17.	  SCID	  and	  C57BL/6JJ	  mice	  were	  obtained	  from	  the	  Jackson	  Laboratory	  (Bar	  Harbor,	  ME).	  Adult	  TCF/LEF-­‐H2BGFP	  were	  backcrossed	  for	  six	  generations	  and	  were	  analyzed	  at	  2	  to	  8	  months	  of	  age.	  	  
Antibodies	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The	  following	  primary	  antibodies	  were	  used	  for	  experiments:	  CD45-­‐PE	  Cy7,	  CD45-­‐APC	  Cy7	  (clone	  30-­‐F11,	  BD	  Bioscience),	  I-­‐A/I-­‐E-­‐APC	  (clone	  M5/114.15.2,	  BD	  Bioscience),	  cytokeratin	  5	  (MK-­‐5,	  Covance),	  cytokeratin	  14	  (MK-­‐14,	  Covance),	  Troma	  I	  (Developmental	  Studies	  Hybridoma	  Bank,	  IA),	  MTS10	  (kindly	  provided	  by	  Dr.	  Richard	  Boyd	  from	  Monash	  University,	  Australia),	  ΔNP63	  (clone	  N-­‐16,	  Santa	  Cruz),	  Aire	  (clone	  M-­‐300,	  Santa	  Cruz),	  EpCAM-­‐PE	  (clone	  G8.8,	  eBioscience),	  Ki67-­‐FITC	  (clone	  B56,	  BD	  Bioscience),	  Ki67	  (clone	  SP6,	  LabVision),	  Sca1-­‐PE	  Cy7,	  Sca1-­‐APC	  Cy7(clone	  D7,	  eBioscience),	  CD49F-­‐Biotin	  (eBioGoH3,	  eBioscience),	  CD29-­‐FITC,	  CD29-­‐PE	  Cy7(clone	  Ha2/5,	  eBioscience)	  ,	  Laminin	  (Millipore).	  CD106-­‐FITC	  (BD	  Bioscience),	  CD140a-­‐Biotin(clone	  APA5,	  eBioscience),	  CD140b-­‐PE	  (clone	  APB5,	  eBioscience),	  CD44-­‐APC	  (clone	  IM7,	  BD	  Bioscience),	  CD90.2(clone	  30-­‐H12,	  BD	  Bioscience),	  CD34-­‐PE	  (clone	  RAM#4,	  eBioscience),	  SSEA1(clone	  MC480,	  Stem	  Cell	  Tecnologies),	  Rabbit	  	  anti-­‐GFP	  (Life),	  CD80	  (eBioscience),	  and	  CD205	  (LY75/DEC-­‐205)	  clone	  HD30	  (Millipore),	  Rat	  IgG2a	  isotype-­‐PE,	  Rat	  IgG2a	  isotype-­‐FITC,	  Rat	  IgG2a	  isotype-­‐PE-­‐Cy7,	  Rat	  IgG2a	  isotype-­‐PerCP	  Cy5.5,	  Rat	  IgG2a	  isotype-­‐APC	  Cy7,	  Rat	  IgG2a	  isotype-­‐APC	  and	  Rat	  IgG2a	  isotype-­‐Biotin	  (BD	  Bioscience).	  	  The	  following	  secondary	  reagents	  were	  used	  for	  experiments:	  donkey	  anti	  rabbit	  IgG-­‐TRITC,	  donkey	  anti	  rabbit	  IgG-­‐Cy5,	  donkey	  anti	  rabbit	  IgG-­‐FITC,	  donkey	  anti	  rat	  IgG-­‐TRITC,	  donkey	  anti	  goat	  IgG-­‐FITC,	  goat	  anti	  rat	  IgM-­‐TRITC	  (Jackson	  ImmunoResearch),	  anti-­‐rat	  IgG2a-­‐FITC,	  anti-­‐rat	  IgM-­‐FITC,	  stretavidin-­‐APC,	  stretavidin-­‐APC	  Cy7,	  streptavidin-­‐PerCP	  Cy5.5	  (BD	  Bioscience)	  and	  stretavidin-­‐TRITC	  (Southern	  Biotechnology	  Associate).	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Thymic	  stromal	  cell	  preparation	  
Embryonic	  thymi	  were	  digested	  with	  Dispase	  (1	  mg/mL)	  and	  Deoxyribonuclease	  I	  solution	  (1	  μg/mL),	  (Stem	  Cell	  Technologies)	  at	  37 C	  for	  15	  minutes	  with	  occasional	  gentle	  agitation	  with	  a	  glass	  Pasteur	  pipette.	  The	  resulting	  single	  cell	  suspension	  was	  washed	  with	  PBS	  and	  passed	  through	  100μm	  strainer	  (BD	  Bioscience)	  to	  remove	  any	  remaining	  undigested	  tissue.	  Adult	  thymi	  were	  cut	  into	  small	  pieces	  and	  the	  majority	  of	  thymocytes	  were	  released	  by	  gentle	  agitation	  using	  a	  glass	  Pasteur	  pipette.	  The	  resulting	  tissue	  fragments	  were	  digested	  with	  Collagenase/Hyaluronidase	  in	  Dulbecco’s	  Modified	  Eagle’s	  Medium	  (Stem	  Cell	  Technologies)	  for	  15	  minutes	  at	  37 C	  followed	  by	  Dispase	  (1	  mg/mL)	  and	  Deoxyribonuclease	  I	  solution	  (0.1	  μg/mL),	  (Stem	  Cell	  Technologies)	  for	  5	  minutes	  at	  37 C.	  The	  single	  cell	  suspension	  was	  washed	  with	  PBS	  and	  passed	  through	  a	  100μm	  strainer	  (BD	  Bioscience).	  	  	  	  
Flow	  cytometery	  
Cells	  were	  suspended	  in	  100	  μl	  of	  FACS	  staining	  buffer	  (FSB-­‐1%	  fetal	  bovine	  serum,	  5	  mM	  EDTA	  and	  0.02%	  NaN3	  in	  PBS)	  with	  appropriately	  diluted	  primary	  antibodies	  for	  20	  minutes	  on	  ice	  in	  the	  dark.	  Secondary	  antibodies	  appropriately	  diluted	  in	  FSB	  were	  added	  cells	  were	  incubated	  for	  an	  additional	  20	  minutes	  on	  ice	  in	  the	  dark.	  After	  washing,	  cells	  were	  resuspended	  in	  500	  μl	  of	  FSB	  for	  data	  acquisition.	  Live/dead	  discrimination	  was	  applied	  using	  ToPro3	  (Invitrogen).	  Data	  acquisition	  was	  performed	  using	  an	  LSRII	  analyzer	  complete	  with	  three	  lasers	  (BD	  Bioscience)	  and	  cell	  sorting	  was	  performed	  using	  a	  FACS	  Aria	  (BD	  Bioscience).	  FACS	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data	  was	  analyzed	  using	  Flow	  Jo	  software	  (Tree	  Star)	  or	  FACS	  Diva	  software	  (BD	  Bioscience).	  
Immunohistochemistry	  and	  confocal	  microscopy	  
Fresh	  tissues	  were	  embedded	  in	  OCT	  medium	  (Fisher);	  snap	  frozen	  and	  sectioned	  (8μm)	  using	  a	  Leica	  CM1950	  Cryostat.	  	  Sections	  were	  air	  dried	  on	  bond-­‐rite	  slides	  and	  then	  fixed	  in	  4%	  paraformaldehyde	  followed	  by	  100%	  ice-­‐cold	  acetone.	  Sections	  were	  washed	  with	  PBS	  and	  blocked	  with	  blocking	  buffer	  (1%	  BSA,	  0.1%Triton-­‐X,	  5%	  normal	  serum	  in	  PBS)	  for	  10	  min.	  Sections	  were	  incubated	  with	  appropriately	  diluted	  primary	  antibodies	  in	  blocking	  buffer	  in	  a	  humidified	  chamber	  for	  1	  hour	  at	  37oC	  followed	  by	  incubation	  with	  secondary	  reagents	  diluted	  in	  blocking	  buffer	  in	  humidified	  chamber	  for	  30	  minutes	  at	  37oC,	  then	  mounted	  with	  ProLong	  gold	  anti-­‐fade	  reagent	  with	  DAPI	  (Invitrogen).	  Isotype	  control	  staining	  was	  performed	  for	  all	  primary	  antibodies	  to	  ensure	  specificity	  of	  staining.	  	  Images	  were	  acquired	  using	  Zeiss	  LSM510	  confocal	  microscope	  and	  analyzed	  using	  LSM	  software	  (Zeiss).	  
RNA	  isolation	  and	  gene	  expression	  analysis	  
Total	  RNA	  was	  isolated	  from	  sorted	  EpCAM+	  thymic	  epithelial	  cells	  or	  cultured	  cells	  using	  Trizol	  reagent	  (Invitrogen).	  RT-­‐PCR	  was	  performed	  using	  SuperScript	  III	  first-­‐strand	  synthesis	  system	  (Invitrogen).	  	  	  End	  point	  PCR	  gene	  expression	  analysis	  of	  sorted	  TECs	  and	  TMSC	  clonal	  lines	  was	  performed	  using	  a	  BioRad	  MyCycler.	  The	  cycling	  condition	  was	  95oC	  for	  2	  minutes	  for	  the	  initial	  denature	  followed	  by	  95oC	  30	  seconds,	  55oC	  30	  seconds	  and	  72oC	  45	  seconds	  for	  40	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cycles	  with	  the	  final	  extension	  of	  5	  minutes	  at	  72oC.	  The	  amplified	  PCR	  products	  were	  visualized	  on	  2%	  agrose	  gel	  containing	  0.5μg/mL	  ethidium	  bromide	  and	  images	  were	  captured	  using	  a	  Kodak	  Gel	  Logic	  100	  for	  documentation.	  The	  primers	  used	  for	  PCR	  analysis	  of	  gene	  expression	  were	  as	  follows,	  listed	  5’-­‐3’:	  
UTF1	  F-­‐GCTCCCCAGTCGTTGAATACC,	  R-­‐CCAGAGAAACGGTTTGGTCG	  [10]	  
FoxD3	  F-­‐CCATCCCCTCACTCACCTAAGC,	  R-­‐AAAGAATGTCCCTCCCACCC	  [10]	  
Lgr5	  F	  -­‐CTTCCGAATCGTCGATCTTC,	  R-­‐AACGATCGCTCTCAGGCTAA	  [21]	  
FoxA1	  F-­‐CTGCAAATGATCAGGAACATAATCC,	  	  
R-­‐CGTGGTGTTAGTTTTAGACAAACGG[10]	  
Cdx1	  F-­‐	  GCACAAGGATGCTATCTGCCC,	  R-­‐TAGAGCCTTCCTCTCCATCCG[10]	  
Nanog	  F-­‐AGGGTCTGCTACTGAGATGCTCTG,	  R-­‐	  CAACCACTGGTTTTTCTGCCACCG[22]	  
Oct4	  F-­‐	  GGCGTTCTCTTTGGAAAGGT,	  R-­‐CTCGAACCACATCCTTCTCT[23]	  
Sox2	  F-­‐AGGGTTCTTGCTGGGTTTTGATT,	  R-­‐CGGTCTTGCCAGTACTTGCTCTC[24]	  
Trp63	  F-­‐CAAAGAACGGCGATGGTACGAAG,	  R-­‐GGCATGTGAGTGCCCATCATA	  [24]	  
Eya1	  F-­‐	  GGTGTGGAAGAAGAGCAAGGG,	  R-­‐TGACACAAGAAGACAAGCCTGC	  [10]	  
FoxN1	  F-­‐	  ACTGACCTGGATGCTATCAACCC,	  R-­‐TGTTTCTGCCAGACAAGGCC	  [10]	  
EpCAM	  F-­‐	  GGGAGTCCCTGTTCCATTCTTC,	  R-­‐CACCCATCTCCTTTATCTCAGC	  [10]	  
MHCII	  F-­‐TCCGTCACAGGAGTCAGAAAGG,	  R-­‐GCTGAGGTGGTGGATACAATAGTACC[10]	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Quantitative	  PCR	  of	  TMSCs	  and	  sorted	  TECs	  
RNA	  was	  denatured	  in	  the	  presence	  of	  Random	  hexamers	  (Applied	  Biosystems	  N808-­‐0127)	  and	  dNTPs	  at	  65OC	  for	  5	  minutes.	  	  The	  denatured	  RNA	  was	  then	  used	  to	  synthesize	  cDNA	  using	  5X	  buffer	  (Invitrogen	  y02321),	  DTT	  (Invitrogen	  y00147),	  SuperScriptIII	  (Invitrogen	  18080-­‐044),	  and	  RNase	  inhibitor	  (Invitrogen	  1077-­‐019)	  at	  25OC	  for	  10	  minutes	  followed	  by	  50OC	  for	  50	  minutes	  and	  85OC	  for	  5	  minutes.	  The	  synthesized	  cDNA	  was	  subsequently	  used	  to	  preform	  quantitative	  real-­‐time	  PCR	  using	  TaqMan	  universal	  master	  mix	  (Applied	  Biosystems	  4369016)	  using	  the	  following	  TaqMan	  assay	  probes	  obtained	  from	  Applied	  Biosciences:	  18srRNA	  (#4333760),	  Foxn1	  (Mm00433946	  m1)	  EpCAM	  (Mm00493214m1)	  Nanog	  (Mm02019550	  s1),	  Oct4	  (Mm03053917	  g1),	  Sox2	  (Mm00488369	  s1).	  	  Applied	  Biosystems	  instrument	  default	  cycling	  protocol	  was	  used	  to	  perform	  q-­‐RT-­‐PCR	  using	  a	  7500	  RT-­‐PCR	  system.	  	  
TMSC	  Cell	  culture	  and	  clonal	  cell	  line	  development	  
Thymic	  stromal	  cells	  were	  harvested	  and	  sorted	  based	  on	  the	  surface	  markers.	  Sorted	  cells	  were	  plated	  on	  96	  well	  plates	  coated	  with	  Laminin/Entactin	  (50μg/mL)	  in	  thymic	  stromal	  culture	  medium,	  MEM	  alpha	  containing	  10%	  fetal	  bovine	  serum,	  penicillin-­‐streptomycin,	  gentamycin	  supplemented	  with	  recombinant	  human	  LIF	  (10ng/mL),	  recombinant	  mouse	  EGF	  (50	  ng/mL)	  and	  recombinant	  bFGF	  (20	  ng/mL)	  (Invitrogen)	  until	  near	  confluence.	  Cells	  were	  gradually	  expanded	  into	  24	  well	  plates,	  6	  well	  plates	  and	  100mm	  plates.	  	  Following	  expansion,	  cells	  were	  cloned	  by	  limiting	  dilution.	  	  	  Cells	  were	  passaged	  every	  7	  days.	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Differentiation	  Assays	  
For	  adipogenic	  differentiation,	  3	  x	  104	  thymic	  stromal	  cells	  or	  clonal	  TMSC	  cell	  lines	  were	  plated/	  well	  of	  6	  well	  plates	  containing	  keratinocyte	  serum	  free	  medium	  (Invitrogen)	  supplemented	  with	  10%	  fetal	  bovine	  serum,	  0.18	  mM	  calcium	  chloride,	  penicillin-­‐streptomycin,	  gentamycin	  and	  recombinant	  mouse	  EGF	  (10	  ng/mL),	  in	  the	  presence	  or	  absence	  of	  5μM	  PPARγ	  inhibitor	  PW9662	  (Sigma	  Aldrich),	  for	  2	  weeks	  with	  the	  medium	  changed	  every	  3-­‐4	  days.	  	  
For	  osteogenic	  differentiation,	  3	  x	  104	  thymic	  stromal	  cells	  or	  cell	  lines	  were	  plated/well	  in	  6	  well	  plates	  containing	  Human/Mouse	  StemXVivo	  Osteogenic/Adipogenic	  Base	  Media	  supplemented	  with	  Mouse	  StemXVivo	  Osteogenic	  Supplement	  (R&D	  systems)	  for	  2	  weeks,	  with	  medium	  changes	  every	  3-­‐4	  days.	  	  
For	  chondrogenic	  differentiation,	  3	  x	  104	  thymic	  stromal	  cells	  or	  clonal	  cell	  lines	  were	  maintained	  as	  a	  pellet	  after	  gentle	  centrifugation	  in	  15	  mL	  Falcon	  tubes	  containing	  Human/Mouse	  StemXVivo	  Chondrogenic	  Base	  Media	  supplemented	  with	  Human/Mouse	  StemXVivo	  Chondrogenic	  Supplement	  (R&D	  systems)	  for	  3	  weeks	  with	  medium	  changes	  every	  3-­‐4	  days.	  Confirmation	  of	  adipogenic,	  osteogenic	  and	  chondrogenic	  differentiation	  were	  performed	  by	  Oil	  red	  O	  staining,	  Alkaline	  phosphatase	  and	  Alizarin	  Red	  S	  staining,	  and	  Alcian	  blue	  staining,	  respectively.	  	  
Mixed	  thymic	  reaggregates	  and	  kidney	  capsule	  transplants	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Fetal	  thymic	  tissue	  was	  harvested	  from	  E15.5	  fetal	  C57BL/6J	  mice.	  	  Tissue	  was	  cleaned	  to	  remove	  excess	  blood	  and	  adhering	  non-­‐thymic	  tissue	  and	  then	  lobes	  were	  torn	  using	  forceps	  and	  washed	  repeatedly	  using	  a	  Pasteur	  pipette	  in	  1	  x	  PBS	  pH	  7.4	  to	  remove	  excess	  thymocytes.	  	  Embryonic	  thymi	  were	  digested	  with	  Dispase	  (1	  mg/mL)	  and	  Deoxyribonuclease	  I	  solution	  (1	  μg/mL),	  (Stem	  Cell	  Technologies)	  at	  37oC	  for	  15	  minutes	  with	  occasional	  gentle	  agitation	  with	  a	  glass	  Pasteur	  pipette.	  The	  resulting	  single	  cell	  suspension	  was	  washed	  with	  PBS	  and	  passed	  through	  100μm	  strainer	  (BD	  Bioscience)	  to	  remove	  any	  remaining	  undigested	  tissue.	  	  Adult	  thymus	  was	  dissociated	  from	  C57BL/6J	  eGFP-­‐expressing	  mice	  (Jax),	  as	  described	  above,	  and	  subsets	  of	  adult	  stromal	  cells	  were	  sorted	  to	  greater	  than	  95%	  purity	  on	  a	  BD	  FACS	  ARIAII	  sorter.	  	  	  2-­‐5	  x105	  dissociated	  fetal	  stroma	  were	  mixed	  with	  1-­‐2	  x	  104	  FACS	  purified	  adult	  eGFP-­‐expressing	  stroma	  and	  centrifuged	  at	  1000G	  on	  a	  microfuge.	  	  Residual	  media	  was	  aspirated	  and	  the	  cell	  pellets	  were	  vortexed	  briefly.	  	  The	  resulting	  slurry	  was	  transferred	  to	  the	  surface	  of	  a	  0.8μm	  polycarbonate	  filter	  (Millipore)	  supported	  on	  a	  transwell	  plate	  above	  RPMI	  FTOC	  medium	  and	  cultured	  for	  48hrs	  at	  37oC	  in	  5%	  CO2.	  	  The	  resulting	  reaggregates	  were	  photographed	  to	  confirm	  the	  presence	  of	  eGFP-­‐expressing	  adult	  cells	  and	  then	  surgically	  transferred	  under	  the	  kidney	  capsule	  of	  nude	  mice	  and	  allowed	  to	  grow	  for	  3	  weeks	  prior	  to	  harvest	  and	  preparation	  of	  cryostat	  sections.	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Chapter	  1	  	  
Identification	  and	  Characterization	  of	  Multipotent	  Mesenchymal	  Stem	  cell	  like	  
Population	  from	  the	  Postnatal	  Thymus	  
	  
Abstract	  	  Thymus	  is	  a	  primary	  lymphoid	  organ	  responsible	  for	  proper	  development	  and	  selection	  of	  T-­‐cells.	  The	  thymic	  microenvironment,	  however,	  undergoes	  age	  related	  involution,	  resulting	  in	  a	  reduction	  of	  the	  repertoire	  of	  T-­‐cells	  that	  are	  produced,	  and	  a	  decreased	  capacity	  to	  respond	  to	  new	  antigen.	  Even	  though	  significant	  thymic	  epithelial	  turnover	  occurs,	  it	  is	  unclear	  if	  postnatal	  thymic	  progenitors/stem	  cell	  are	  responsible	  for	  the	  maintenance	  of	  the	  TEC	  microenvironment.	  Here	  we	  use	  the	  K5rtTA:TetO-­‐H2BGFP	  transgenic	  model	  to	  identify	  a	  slow	  cycling	  potential	  stem	  cells/progenitor	  population	  in	  the	  postnatal	  thymus.	  These	  cells	  were	  isolated,	  expanded	  in	  culture,	  and	  successfully	  differentiated	  into	  adipocytes,	  chondrocytes	  and	  osteoblasts.	  We	  identified	  that	  the	  culture	  expanded	  LRCs	  expressed	  the	  surface	  makers	  PDGFRα,	  PDGFRβ,	  SCA1,	  CD29,	  CD44,	  CD49f,	  and	  CD90	  identical	  to	  markers	  used	  to	  characterize	  mesenchymal	  stem	  cells.	  LRC	  were	  isolated	  and	  maintained	  as	  a	  thymic	  mesenchymal	  stem	  cell	  line	  (TMSC),	  which	  showed	  a	  limited	  capability	  for	  forming	  a	  reaggregated	  thymus	  when	  combined	  with	  fetal	  epithelium.	  Dexamethasone	  treatment	  of	  the	  mouse	  resulted	  in	  depletion	  of	  the	  label	  as	  the	  thymus	  recovered	  from	  drug	  induced	  involution,	  suggesting	  that	  LRC	  are	  recruited	  during	  thymic	  regeneration.	  Collectively	  these	  results	  demonstrate	  we	  have	  identified	  a	  stem	  cell	  population	  in	  the	  postnatal	  thymus	  that	  may	  play	  a	  role	  in	  the	  maintenance	  of	  the	  thymic	  architecture.	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Introduction	  	   Postnatal	  stem	  cells	  are	  undifferentiated	  cells	  that	  have	  the	  unique	  ability	  to	  produce	  differentiated	  daughter	  cells	  while	  retaining	  their	  stem	  cell	  identity	  [25].	  They	  maintain	  an	  extraordinary	  capability	  to	  proliferate	  and	  counteract	  tissue	  damage	  [26].	  	  Several	  adult	  tissues,	  including	  the	  bone	  marrow,	  epidermis,	  hair	  follicle,	  intestine,	  brain,	  testis	  and	  cornea	  have	  been	  shown	  to	  contain	  stem	  cell	  populations	  [27-­‐29].	  	  Furthermore	  the	  label	  retention	  model	  used	  in	  this	  study	  has	  been	  previously	  used	  to	  identify	  the	  epithelial	  stem	  cell	  niche	  in	  skin	  [30].	  	  Here	  we	  use	  a	  similar	  model	  to	  identify	  and	  isolate	  a	  thymic	  mesenchymal	  stem	  cell	  (TMSC)	  population	  from	  the	  postnatal	  thymus.	  Mesenchymal	  stem	  cells	  are	  virtually	  present	  in	  all	  tissues	  and	  organs	  [31-­‐33];however	  only	  exist	  in	  a	  minority	  status.	  They	  are	  a	  multipotent	  stromal	  tissue	  capable	  of	  differentiation	  into	  numerous	  tissue	  types	  including	  adipocytes,	  chondrocytes,	  and	  osteoblast	  [34-­‐36]	  furthermore	  they	  also	  show	  the	  ability	  to	  maintain	  hematopoietic	  stem	  cells	  in	  an	  in	  vitro	  environment	  
[37].	  	  Moreover	  mesenchymal	  cells	  have	  also	  shown	  the	  capability	  of	  converting	  into	  epithelial	  cells	  during	  embryogenesis,	  as	  a	  physiological	  response	  to	  injury	  in	  postnatal	  mice	  as	  well	  as	  in	  cancer	  cells	  [38].	  
	   Due	  to	  their	  limited	  numbers,	  isolation	  and	  identification	  of	  these	  postnatal	  stem	  cells	  has	  evaded	  many	  scientists	  and	  has	  primarily	  relied	  on	  anatomical	  characteristics	  and	  their	  quiescent	  state.	  A	  novel	  H2BGFP	  transgenic	  mouse	  model	  has	  been	  utilized	  to	  identify	  infrequently	  cycling	  cells	  using	  a	  TET-­‐OFF	  regulatory	  system	  (Figure	  1)	  [30,	  39].	  As	  stem	  cells	  are	  known	  to	  be	  quiescent,	  they	  will	  retain	  the	  label	  as	  the	  proliferating	  cells	  dilute	  it.	  We	  utilized	  this	  identical	  system	  to	  help	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identify	  both	  the	  intra	  thymic	  localized	  and	  phenotype	  of	  LRCs	  from	  the	  thymus.	  These	  LRCs	  were	  then	  sorted	  using	  H2BGFP	  expression	  and	  cultured	  to	  create	  a	  clonal	  line,	  which	  was	  then	  used	  to	  further	  test	  for	  their	  stem	  cell	  potential.	  	  	  
	   The	  sorted	  LRCs	  were	  capable	  of	  in	  vitro	  growth	  potential,	  and	  exhibited	  several	  surface	  makers	  that	  have	  been	  previously	  shown	  to	  be	  markers	  of	  stemness.	  These	  cells	  were	  also	  capable	  of	  differentiating	  into	  adipocytes,	  chondrocytes	  and	  osteocytes	  suggesting	  the	  cells	  were	  highly	  similar	  to	  mesenchymal	  stem	  cells	  (MSC).	  The	  ability	  of	  mesenchymal	  cells	  isolated	  from	  other	  tissues	  to	  undergo	  MET	  
[38]	  suggests	  they	  may	  be	  capable	  of	  differentiating	  into	  TECs	  in	  culture.	  	  In	  an	  in	  
vivo	  study,	  these	  LRC	  in	  mice	  under	  went	  a	  loss	  of	  label	  retention	  as	  thymic	  tissue	  following	  a	  dex	  induced	  transient	  thymic	  involution	  assay.	  This	  demonstrated	  the	  proliferation	  capability	  of	  the	  LRCs,	  when	  placed	  in	  a	  tissue	  repair	  environment,	  which	  has	  been	  previously	  demonstrated	  by	  other	  quiescent	  stem	  cells	  [25].	  Sorted	  LRC’s	  also	  showed	  a	  limited	  capability	  of	  becoming	  TECs	  in	  reaggregate	  thymic	  organ	  culture	  (RTOC)	  after	  surgical	  transplant	  under	  the	  kidney	  capsule	  of	  nude	  mice.	  Together	  these	  results	  demonstrate	  the	  we	  have	  identified	  and	  localized	  a	  multipotent	  stem	  cell	  population	  from	  the	  thymus	  that	  becomes	  mesenchymal	  stem	  cell	  following	  culture	  in	  vitro	  and	  that	  proliferates	  in	  vivo	  for	  thymus	  architecture	  recovery.	  	  
Results	  
Use	  of	  Label	  retention	  to	  identify	  a	  subset	  of	  quiescent	  epithelial	  cells	  in	  the	  postnatal	  
thymus.	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The	  model	  used	  to	  identify	  label	  retaining	  stem	  cells	  is	  a	  typical	  tet-­‐off	  model	  	  (K5tTA;TetO-­‐H2BGFP),	  	  In	  this	  double	  transgenic	  model	  a	  strain	  containing	  tetracycline	  controlled	  transactivator	  driven	  by	  the	  Keratin	  5	  (K5)	  promoter	  (K5tTA)	  is	  bred	  to	  mice	  containing	  a	  transgene	  consisting	  of	  a	  tetracycline	  response	  element	  (TRE)	  attached	  to	  a	  CMV	  promoter	  controlling	  production	  of	  histone	  2B	  green	  florescence	  protein	  fusion	  protein	  (TetO-­‐H2BGFP).	  Hence	  in	  the	  absence	  of	  the	  tetracycline	  analog	  doxycycline	  (Dox),	  all	  K5	  positive	  TECs	  express	  H2BGFP	  in	  their	  nucleus.	  Feeding	  Dox	  results	  in	  inactivation	  of	  transactivator	  protein	  and	  subsequent	  loss	  of	  production	  of	  H2BGFP	  (Figure	  1).	  As	  a	  result	  all	  the	  rapidly	  proliferating	  cells	  will	  lose	  H2BGFP	  fluorescence.	  Only	  the	  quiescent	  cells	  will	  retain	  the	  label.	  This	  model	  allows	  for	  sorting	  of	  viable	  LRC	  based	  on	  H2BGFP	  expression.	  In	  order	  to	  determine	  the	  kinetics	  of	  H2BGFP	  dilution	  and	  identify	  true	  LRCs,	  we	  fed	  the	  double	  transgenic	  mice	  for	  12	  weeks	  with	  doxycycline,	  euthanizing	  cohorts	  of	  mice	  at	  time	  0,	  2,	  4,	  6	  and	  12	  week	  after	  initiating	  Dox	  feeding.	  	  
The	  resulting	  thymic	  lobes	  were	  then	  utilized	  for	  immunohistochemistry	  and	  FACS	  analysis.	  The	  sections	  were	  stained	  with	  antibodies	  against	  K5	  and	  K8,	  as	  K5	  identifies	  the	  dominant	  mTEC	  population	  and	  K8	  identifies	  the	  cTECs	  and	  a	  small	  subset	  of	  mature	  mTECs.	  	  It	  was	  observed	  that	  all	  K5	  positive	  cells	  were	  H2BGFP	  positive	  at	  time	  0,	  however	  as	  the	  time	  progressed	  the	  rapidly	  dividing	  cells	  began	  to	  dilute	  the	  label	  hence	  increasing	  the	  total	  number	  of	  H2BGFP	  positive	  cells	  (Figure	  2	  A&C)	  but	  decreasing	  the	  intensity	  of	  H2BGFP	  (Figure	  2	  A&B).	  True	  LRCs	  were	  identified	  after	  6	  weeks	  of	  doxycycline	  feeding	  as	  the	  number	  of	  H2BGFP	  cells	  both	  with	  high	  and	  low	  intensity	  was	  approximately	  the	  same	  when	  compared	  to	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Dox	  treatment	  for	  12	  week	  suggesting	  that	  a	  minimum	  of	  6	  weeks	  was	  needed	  to	  identify	  the	  LRCs	  (Figure	  2C	  &	  3D).	  Histological	  analysis	  revealed	  that	  after	  6	  weeks,	  the	  majority	  of	  the	  LRCs	  were	  at	  the	  CMJ,	  and	  displayed	  a	  K5+	  K8+	  double	  positive	  phenotype	  (Figure	  2A	  400X).	  K5	  K8	  double	  positive	  TECs	  located	  at	  the	  CMJ	  have	  been	  proposed	  to	  contain	  TEC	  progenitors	  by	  several	  groups	  [40-­‐43].	  	  EpCAM	  is	  the	  most	  defined	  epithelial	  marker	  used	  to	  identify	  TECs	  [32].	  No	  significant	  change	  in	  total	  EpCAM	  positive	  cells	  recovered	  was	  observed	  between	  time	  0	  and	  12	  weeks	  (Figure	  2D).	  Hence	  supporting	  our	  initial	  hypothesis	  that	  quiescent	  cells	  retaining	  the	  label	  will	  be	  present	  in	  population	  previously	  believed	  to	  contain	  TEC	  progenitors	  [41,	  42].	  	  
Characterization	  and	  isolation	  of	  the	  label	  retaining	  cells	  from	  the	  thymus.	  
We	  then	  wanted	  to	  determine	  if	  the	  label	  retention	  was	  a	  result	  of	  terminal	  differentiation	  or	  the	  slow	  cycling	  property	  of	  stem	  cells.	  In	  order	  to	  do	  so	  we	  took	  frozen	  thymi	  from	  a	  3	  week	  	  (Time	  0)	  old	  double	  transgenic	  mice	  without	  Dox	  feeding	  and	  compared	  it	  to	  a	  double	  transgenic	  that	  was	  fed	  dox	  for	  10	  weeks	  (Figure	  3A,	  B,	  C	  &	  D).	  We	  observed	  abundant	  H2BGFP	  expression	  at	  time	  0	  when	  compared	  to	  10	  weeks	  (Figure	  3A&B).	  It	  was	  further	  confirmed	  that	  H2BGFP	  expressing	  cells	  were	  K5+K8+	  and	  located	  at	  the	  CMJ	  after	  Dox	  feeding	  (Figure	  3D	  and	  inserts).	  Staining	  with	  Ki67	  revealed	  no	  proliferation	  was	  taking	  place	  in	  LRCs	  found	  in	  10	  week	  Dox	  fed	  mice	  (Figure	  3E)	  as	  is	  expected	  from	  quiescent	  stem	  cells	  
[25].	  Since	  the	  mice	  had	  a	  K5	  driven	  promoter	  we	  used	  an	  additional	  marker	  of	  mTECs	  to	  specifically	  identify	  immature	  mTEC	  subset,	  MTS10	  (immature	  mTEC	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marker)	  to	  confirm	  these	  cells	  were	  mTECs.	  Most	  LRCs	  at	  after	  10	  weeks	  of	  Dox	  feeding	  were	  MTS10	  positive	  but	  were	  primarily	  located	  at	  the	  edge	  of	  medullary	  cluster	  near	  the	  CMJ	  (Figure	  3E).	  	  
Label	  retention	  might	  also	  be	  expected	  in	  terminally	  differentiated	  cells	  that	  had	  stopped	  dividing.	  	  To	  specifically	  determine	  if	  the	  H2BGFP	  expressing	  cells	  were	  differentiated	  cells	  or	  immature	  stem	  cells/TEC	  progenitors	  sections	  were	  stained	  with	  Aire	  antibody,	  which	  identifies	  differentiated	  mature	  mTECs	  along	  with	  ΔNP63,	  which	  has	  been	  shown	  to	  be	  a	  marker	  of	  stem	  cells	  in	  skin	  epithelium	  [42,	  44-­‐48].	  	  Expression	  of	  ΔNP63	  is	  also	  lost	  as	  the	  cells	  differentiate	  [49,	  50].	  Hence	  Aire	  expressing	  cells	  represent	  more	  differentiated	  TECs	  while	  ΔNP63	  expressing	  cells	  should	  be	  immature	  TECs	  with	  proliferative	  potential	  and	  may	  be	  capable	  of	  multipotency.	  Additionally	  we	  also	  used	  Ulex	  Europrus	  Agglutinin-­‐1	  (UEA1)	  to	  stain	  for	  terminally	  differentiated	  cells	  as	  the	  UEA1	  lectin	  binds	  strongly	  to	  the	  mature	  mTECs.	  We	  observed	  that	  none	  of	  the	  LRCs	  were	  Aire	  positive	  or	  UEA1	  positive	  (Figure	  3F&G	  arrows),	  however	  100%	  were	  ΔNP63	  positive	  (Figure	  3F).	  We	  used	  an	  additional	  marker	  for	  cTEC,	  DEC205	  to	  confirm	  LRCs	  were	  at	  the	  CMJ	  when	  compared	  to	  non-­‐Dox	  fed	  mice.	  LRCs	  were	  found	  at	  the	  CMJ	  when	  compared	  to	  the	  control	  (Figure	  3G&H)	  and	  many	  were	  also	  expressing	  DEC205	  .	  These	  results	  illustrate	  that	  LRCs	  are	  not	  terminally	  differentiated	  or	  undergoing	  proliferation,	  additionally	  they	  stain	  positive	  for	  stem	  cell	  markers	  and	  belong	  to	  an	  immature	  subset	  of	  the	  TEC	  population	  expressing	  both	  cTEC	  and	  mTEC	  characteristic.	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Further	  characterization	  of	  LRCs	  was	  done	  using	  flow	  cytometry	  to	  determine	  which	  subsets	  of	  TECs	  contain	  LRCs.	  In	  order	  to	  identify	  cell	  surface	  markers	  the	  thymic	  lobes	  were	  dissociated	  both	  prior	  to	  dox	  feeding	  as	  well	  as	  2,	  4,	  and	  6	  weeks	  after	  Dox	  feeding.	  The	  cells	  were	  then	  gated	  on	  CD45	  negative	  cells	  to	  exclude	  T-­‐cells,	  macrophages	  and	  dendritic	  cells	  from	  the	  analysis	  (Figure	  4).	  The	  cells	  were	  then	  separated	  based	  on	  their	  EpCAM,	  MHCII,	  and	  H2BGFP	  expression.	  This	  surface	  staining	  is	  routinely	  used	  to	  distinguish	  between	  TECs	  and	  non-­‐TECs	  subset	  from	  a	  dissociated	  thymus	  as	  EpCAM+	  defines	  the	  TEC	  population	  within	  the	  thymus.	  MHCIIhi	  and	  EpCAM+	  phenotype	  further	  distinguishing	  the	  mature	  mTECs,	  and	  the	  MHCIIlo	  EpCAM+	  phenotype	  defines	  the	  immature	  mTECs	  and	  cTECs.	  	  The	  non-­‐TEC	  populations	  of	  the	  stroma	  (mostly	  composed	  of	  fibroblast	  and	  endothelium)	  are	  defined	  by	  MHCII+EpCAMneg	  and	  MHCII-­‐EpCAM-­‐	  subsets[14,	  51].	  	  After	  6	  weeks	  of	  dox	  feeding,	  LRCs	  were	  highly	  enriched	  in	  the	  EpCAMhiMHCIIlo	  populations	  consisting	  of	  the	  more	  immature	  mTEC	  and	  cTEC	  populations.	  There	  was	  also	  a	  steady	  presence	  of	  LRCs	  in	  the	  MHCIIlo/negEpCAMlo	  population	  (Figure	  4B).	  This	  population	  has	  not	  been	  previously	  defined.	  Hence	  our	  flow	  cytometry	  analysis	  further	  confirms	  our	  IHC	  results,	  as	  well	  as	  showing	  that	  LRCs	  include	  a	  new	  population	  of	  TECs,	  which	  have	  previously	  remained	  undefined.	  Furthermore	  the	  LRCs	  exhibit	  an	  immature	  TEC	  phenotype	  and	  may	  represent	  precursors	  to	  TECs.	  	  
In	  an	  effort	  to	  further	  define	  the	  phenotype	  of	  LRCs,	  additional	  markers	  previously	  used	  to	  characterize	  stem	  cell	  subsets	  were	  utilized.	  Three	  months	  old	  C57/Black6	  mice	  were	  used	  to	  characterize	  the	  expression	  of	  Sca1	  (Stem	  Cell	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Antigen-­‐1)	  in	  different	  subsets	  of	  TECs.	  Sca1	  is	  the	  most	  recognized	  HSC	  marker	  in	  mice	  [52-­‐56].	  Sca1	  has	  also	  been	  used	  as	  a	  marker	  to	  enrich	  for	  progenitor	  populations	  in	  other	  tissues,	  including	  epithelial	  stem	  cells	  [30,	  57]	  and	  MSCs[58].	  Sca1	  is	  also	  used	  in	  combination	  with	  CD29	  and	  CD49-­‐f	  integrins,	  to	  localize	  MSCs	  and	  epithelial	  stem	  cells	  within	  stem	  cell	  niche.	  CD29	  and	  CD49f	  intergrins	  are	  known	  to	  be	  associated	  with	  the	  stem	  cells	  niches	  as	  they	  help	  them	  bind	  to	  laminin	  rich	  regions	  where	  the	  majority	  of	  stem	  cells	  are	  usually	  located.	  Using	  this	  information,	  we	  wanted	  to	  observe	  if	  the	  LRCs	  expressed	  CD29	  and	  CD49f	  on	  the	  surface	  of	  the	  cells.	  [65-­‐68]	  
Analysis	  of	  the	  different	  subsets	  of	  TECs	  for	  Sac1	  showed	  that	  the	  MHCIIlo/negEpCAMlo	  population	  contained	  35%	  Sca1	  expressing	  cells,	  while	  the	  MHCIIhiEpCAMhi	  that	  defines	  the	  mature	  TECs,	  contained	  23%	  Sca1	  expressing	  cells,	  while	  70%	  of	  the	  MHCIIloEpCAMhi	  subset	  was	  Sca1	  expressing	  (Figure	  5A&B),	  showing	  an	  enrichment	  of	  stem	  cells	  markers.	  Sca1	  positive	  and	  negative	  subsets	  were	  further	  characterized	  for	  CD29CD49F	  expression	  as	  these	  markers	  together	  have	  been	  used	  in	  several	  studies	  to	  isolate	  stem	  cells.	  It	  was	  observed	  that	  all	  Sca1	  negative	  TECs	  were	  CD29lo/negCD49lo/neg(Figure	  5D),	  whereas	  the	  Sca1	  positive	  TECs	  from	  the	  MHCIIhiEpCAMhi	  subset	  were	  CD49FhiCD29+,	  which	  was	  also	  observed	  in	  MHCIIloEpCAMhi	  subset	  of	  TECs.	  However	  the	  new	  TECs	  population	  (MHCIIlo/negEpCAMlo)	  described	  here	  had	  two	  distinct	  populations	  including	  both	  a	  less	  abundant	  of	  CD49FloCD29+	  subset	  and	  a	  dominant	  CD49FhiCD29+	  subset	  (Figure	  5C).	  Sca1	  expression	  was	  not	  observed	  in	  the	  MHCIInegEpCAMneg	  non-­‐TEC	  stromal	  population	  (data	  not	  shown).	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We	  next	  examined	  the	  expression	  of	  Sca1	  on	  different	  subsets	  of	  LRCs.	  It	  was	  observed	  that	  the	  bulk	  of	  H2BGFPhi	  and	  H2BGFPlo	  LRCs	  were	  progressively	  selecting	  for	  the	  Sca1	  positive	  subset	  of	  TECs	  after	  6	  weeks	  of	  dox	  feeding	  when	  compared	  to	  the	  non-­‐dox	  fed	  control	  (Figure	  5E).	  Again	  showing	  enrichment	  of	  stem	  cell	  markers	  in	  the	  LRCs.	  Many	  LRCs	  after	  10	  weeks	  of	  Dox	  feed	  expressed	  the	  MHCIIlo/negEpCAMlo	  phenotype	  (Figure	  5F),	  this	  population	  of	  the	  thymus	  has	  not	  been	  previously	  described	  and	  showed	  an	  enrichment	  of	  LRCs	  in	  a	  new	  population	  of	  TECs	  that	  were	  also	  enriched	  in	  Sca1	  expression.	  Furthermore	  we	  characterized	  UEA1	  and	  BP1	  expression	  by	  flow	  cytometry	  of	  the	  LRCs	  to	  determine	  if	  we	  were	  enriching	  for	  cTECs	  or	  mTECs,	  since	  BP1	  is	  a	  cTEC	  marker	  and	  UEA1	  is	  used	  to	  identify	  mTECs	  It	  was	  observed	  that	  LRCs	  were	  predominately	  BP1+	  cTECs	  and	  dim	  for	  UEA1	  binding	  mTECs.	  These	  flow	  cytomentry	  results	  correlate	  well	  with	  the	  histology	  which	  show	  LRCs	  residing	  at	  the	  CMJ	  (Figure	  5F).	  We	  further	  examined	  Sca1	  positive	  cells	  for	  CD29CD49F	  expression	  to	  determine	  if	  they	  were	  enriched	  for	  these	  integrins	  associated	  with	  the	  stem	  cell	  niche,	  in	  the	  different	  subsets	  of	  TECs.	  As	  before,	  we	  observed	  the	  presence	  of	  both	  the	  CD29hiCD49flo	  as	  well	  as	  the	  CD29hiCD49fhi	  populations	  in	  the	  MHCIIlo/negEpCAMlo	  subset	  and	  only	  the	  CD29hiCD49fhi	  population	  in	  MHCIIloEpCAMhi	  subset	  (Figure	  5G).	  These	  results	  show	  that	  LRCs	  are	  enriched	  in	  Sca1+	  cells	  as	  well	  as	  two	  distinct	  populations	  based	  on	  CD29	  and	  CD49f	  expression	  levels.	  To	  further	  analyze	  the	  stem	  cell	  characteristic	  of	  LRCs,	  we	  examined	  their	  in	  vitro	  growth	  potential,	  as	  stem	  cells	  isolated	  from	  varies	  sources	  often	  retain	  the	  capacity	  to	  form	  colonies	  in	  vitro[30,	  58-­‐60].	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In	  order	  to	  test	  if	  the	  distinct	  subset	  of	  LRCs	  defined	  by	  differential	  expression	  of	  MHCII,	  Epcam,	  Sca1,	  CD49f,	  and	  CD29	  exhibited	  in	  vitro	  growth	  potential,	  we	  sorted	  the	  CD45negEpCAMloMHCIIlo/-­‐Sca1+	  as	  well	  as	  the	  CD45negEpCAMhiMHCIIloSca1+	  TEC	  subsets	  of	  the	  LRCs	  from	  ten	  dissociated	  thymi	  after	  10	  weeks	  on	  dox	  food	  to	  more	  than	  95%	  purity.	  The	  cells	  were	  plated	  at	  a	  density	  of	  3x103	  cells/plate	  in	  a	  35mm	  plate,	  which	  was	  pre-­‐coated	  with	  laminin.	  The	  cells	  were	  cultured	  with	  LIF,	  EGF	  and	  FGF	  recombinant	  proteins	  and	  10%	  ESFBS	  to	  maintain	  the	  stem	  cells	  in	  an	  undifferentiated	  state	  in	  culture.	  We	  observed	  that	  the	  CD45negEpCAMhiMHCIIloSca1+	  TEC	  subset	  had	  limited	  growth	  potential	  (Figure	  6B).	  After	  counting	  the	  colonies	  it	  was	  determined	  only	  0.002%	  of	  cells	  isolated	  from	  CD45negEpCAMhiMHCIIloSca1+	  TEC	  subset	  were	  capable	  in	  forming	  colonies	  (Figure	  6B&I),	  however	  the	  CD45negSac1+EpCAMloMHCIIlo/-­‐	  subset	  exhibited	  a	  significantly	  higher	  growth	  potential	  of	  0.04%	  (Figure	  6A&I).	  	  We	  also	  observed	  the	  return	  of	  the	  H2BGFP	  expression	  since	  these	  cells	  were	  no	  longer	  in	  the	  presence	  of	  Dox	  and	  proving	  they	  were	  derived	  from	  the	  LRCs	  (Figure	  6C-­‐F).	  In	  contrast	  the	  Sca1+EpCAMhiMHCIIlo	  cells	  only	  divided	  a	  few	  times	  (Figure	  6D&F)	  however,	  the	  Sca1+EpCAMloMHCIIlo/neg	  cells	  grew	  rapidly,	  reaching	  confluence	  within	  4	  days	  of	  plating	  (Figure	  6C&E).	  We	  have	  now	  identified	  a	  population	  of	  cells	  (Sca1+EpCAMloMHCIIlo/neg)	  that	  has	  in	  vitro	  growth	  potential,	  however	  only	  a	  small	  subset	  of	  cells	  isolated	  (0.04%)	  from	  this	  population	  showed	  this	  potential.	  To	  further	  enrich	  for	  TECs	  with	  growth	  potential	  we	  used	  Sca1	  together	  with	  CD29	  and	  CD49F	  to	  sort	  the	  TEC	  subset	  enriched	  in	  the	  LRC	  subset.	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We	  wanted	  to	  further	  investigate	  which	  subsets	  of	  Sca1+MHCIIlo/negEpCAMlo	  were	  capable	  of	  in	  vitro	  growth	  potential	  based	  on	  CD45F	  and	  CD29	  expression.	  	  We	  sorted	  TECs	  from	  C57BL6	  mice,since	  we	  no	  longer	  need	  label	  retention	  to	  identify	  the	  subset	  of	  cells	  with	  growth	  potential,	  and	  could	  compare	  the	  colony	  forming	  potential	  of	  both	  the	  Sca1+MHCIIlo/negEpCAMloCD49FhiCD29+	  as	  well	  as	  the	  Sca1+MHCIIlo/negEpCAMloCD49FloCD29+	  subset	  (Figure	  6G&H)	  using	  C57BL6	  mice.	  The	  CD29+CD49Flo	  subset	  exhibited	  a	  significantly	  enhanced	  colony	  formation	  potential	  with	  mean	  colony	  frequency	  of	  0.14%	  (Figure	  6G&I).	  Little	  to	  no	  growth	  was	  observed	  in	  the	  CD29+CD49Fhi	  population	  (Figure	  6H&I).	  Together	  these	  results	  demonstrate	  that	  thymic	  derived	  LRCs	  have	  in	  vitro	  growth	  potential	  similar	  to	  other	  stem	  cells.	  Furthermore	  we	  have	  shown	  that	  this	  in	  vitro	  growth	  potential	  resides	  within	  the	  TEC	  subset	  characterized	  by	  the	  phenotype	  MHCIIlo/negEpCAMloSca1+CD29+CD49Flo.	  To	  further	  investigate	  and	  identify	  the	  stem	  cell	  potential	  of	  these	  cells	  I	  subsequently	  made	  multiple	  clonal	  lines	  were	  generated,	  which	  exhibited	  a	  mesenchymal	  phenotype	  when	  observed	  under	  light	  microscope	  (Figure7	  A&B).	  
To	  determine	  if	  these	  cell	  lines	  were	  similar	  to	  mesenchymal	  stem	  cells	  (MSCs)	  derived	  from	  other	  tissues,	  we	  tested	  the	  ability	  of	  these	  cells	  to	  differentiate	  as	  well	  as	  characterized	  their	  surface	  expression	  using	  a	  previously	  defined	  panel	  of	  surface	  markers	  used	  to	  define	  mesenchymal	  stem	  cells.	  Culture	  expanded	  heterogeneous	  LRCs	  were	  capable	  of	  differentiating	  into	  multiple	  mesenchymal	  lineages	  such	  as	  adipocytes,	  chondrocytes	  and	  osteocytes,	  as	  well	  as	  expressing	  a	  surface	  phenotype	  previously	  used	  to	  identified	  to	  mesenchymal	  stem	  cells	  (Data	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not	  shown).	  However,	  since	  this	  was	  a	  heterogeneous	  population	  of	  cells	  we	  could	  not	  state	  for	  a	  fact	  that	  all	  the	  cells	  had	  the	  capability	  of	  differentiating	  into	  all	  mesenchymal	  lineages.	  In	  order	  to	  answer	  this	  question	  we	  set	  out	  to	  make	  clonal	  cell	  lines	  and	  characterize	  the	  surface	  profile	  using	  the	  same	  MSCs	  markers.	  Single	  cells	  were	  plated	  into	  96	  well	  plate	  and	  expanded	  until	  they	  reached	  80%	  confluence	  10cm	  plates	  (Figure	  7A&B).	  Further	  staining	  of	  2	  of	  these	  clonal	  lines	  followed	  by	  flow	  analysis	  revealed	  that	  thymic	  LRCs	  maintained	  a	  strong	  and	  consistent	  expression	  of	  Sca1,	  CD29,	  CD44,	  and	  PDGFRalpha.	  They	  also	  expressed	  CD34,	  CD49F,	  PDGFRbeta,	  CD90,	  and	  SSEA1	  at	  lower	  levels	  (Figure	  8A).	  All	  these	  markers	  have	  been	  previously	  used	  together	  to	  identify	  mesenchymal	  stem	  cells.	  These	  cells	  were	  also	  shown	  to	  maintain	  EpCAM	  and	  MHCII	  expression	  upon	  initial	  analysis	  however	  these	  markers	  were	  eventually	  lost	  (Figure	  8A).With	  the	  exception	  of	  MHCII	  and	  EpCAM	  this	  pattern	  of	  surface	  markers	  is	  identical	  to	  results	  reported	  with	  MSCs	  isolated	  from	  other	  tissues	  [28,	  59,	  61].	  We	  thus	  named	  these	  cells	  lines	  Thymic	  Menenchymal	  Stem	  Cells	  (TMSC).	  
	   Gene	  expression	  studies	  were	  performed	  to	  further	  characterize	  the	  TMSC	  lines.	  Real	  Time-­‐Polymerase	  Chain	  Reaction	  (RT-­‐PCR)	  of	  RNA	  isolated	  from	  clonal	  cell	  lines	  was	  examined	  to	  determine	  the	  expression	  of	  transcription	  regulators	  that	  have	  been	  reported	  to	  be	  active	  in	  pluripotent	  cells	  including	  nanog,	  octamer-­‐binding	  transcription	  factor	  4	  (Oct4),	  and	  sex	  determining	  region	  Y-­‐2	  (Sox2)[48].	  In	  addition	  we	  also	  looked	  at	  two	  well	  define	  molecules	  for	  TECs,	  EpCAM	  and	  forkhead	  box	  protein	  N1	  (FOXN1)	  gene	  expression.	  The	  FOXN1	  gene	  is	  important	  for	  TEC	  development	  [49-­‐50].	  As	  a	  control	  we	  compared	  expression	  against	  freshly	  isolated	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cells	  from	  the	  thymus	  including	  the	  MHCIIlo	  EpCAMloSca1+CD49FloCD29+,	  MHCIIloEpCA	  MloSca1+CD49FhiCD29+,	  MHCIIhiEpCAMhiSca1-­‐,	  and	  MHCIIlo/intEpCAMhiSca1+CD29+	  subsets.	  Gene	  expression	  results	  showed	  limited	  expression	  of	  TEC	  markers	  like	  FOXN1	  and	  EpCAM;	  however	  Nanog	  and	  Sox2	  expression	  exhibited	  a	  2.5	  and	  6	  fold	  increase	  respectively,	  between	  the	  MHCIIlo/intEpCAMhiSca1+CD29+	  (known	  to	  contain	  both	  cTECs	  and	  immature	  mTECs)	  and	  the	  MHCIIloEpCAMloSca1+CD49FloCD29+	  subsets	  (Figure	  8B).	  It	  was	  also	  observed	  that	  the	  TMSC	  clonal	  line	  had	  a	  significant	  reduction	  in	  TEC	  markers	  compared	  to	  the	  cells	  they	  were	  originally	  isolated	  from	  (TMSC7-­‐10	  vs.	  the	  MHCIIloEpCAMloSca1+CD49FloCD29+	  subset)	  as	  well	  as	  a	  decrease	  in	  the	  expression	  of	  pluripotent	  stem	  cell	  markers	  like	  Nanog,	  Oct4,	  and	  Sox2	  (Figure	  8B).	  These	  results	  suggested	  that	  these	  stem	  cell	  genes	  may	  not	  be	  contributing	  to	  the	  in	  vitro	  growth	  potential	  of	  the	  TMSC	  clonal	  cells	  or	  that	  the	  lower	  expression	  level	  observed	  is	  sufficient	  to	  maintain	  in	  vitro	  growth	  potential.	  	  
Differentiation	  of	  the	  label	  retaining	  cells	  (LRC)	  into	  mesenchymal	  lineages.	  
	   To	  definitively	  prove	  that	  we	  had	  isolated	  MSCs	  from	  the	  thymus	  we	  differentiated	  both	  the	  clones	  TMCS	  7-­‐10	  and	  TMCS	  2-­‐1	  cells	  into	  adipocytes,	  chondrocytes	  and	  osteoblasts.	  Differentiation	  into	  adipocytes	  was	  indicated	  using	  oil	  red	  O	  staining	  of	  oil	  droplets	  in	  the	  TMSC	  7-­‐10	  cells	  after	  culture	  in	  adipo	  media.	  No	  staining	  was	  observed	  in	  control	  TMSC	  7-­‐10	  cells	  cultured	  in	  normal	  media	  (Figure	  9A&B).	  It	  was	  also	  observed	  that	  late	  passage	  TEC	  lines	  had	  a	  tendency	  to	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differentiate	  towards	  adipocytes	  when	  in	  a	  confluent	  environment,	  similar	  to	  results	  seen	  with	  aging	  thymus	  [14].	  	  	  
	   TMSC	  7-­‐10	  cells	  also	  differentiated	  into	  osteoblast	  when	  subjected	  to	  media	  that	  drives	  differentiation	  into	  osteoblasts,	  while	  no	  cells	  differentiated	  under	  normal	  growth	  conditions	  and	  were	  maintained	  as	  stem	  cells.	  Osteoblast	  were	  observed	  using	  alizarin	  red	  S	  staining	  (Figure	  9C&D),	  which	  stains	  the	  mineral	  deposits	  or	  alkaline	  phosphatase	  activity	  (data	  not	  shown).	  Similarly	  the	  TMSC	  7-­‐10	  also	  were	  capable	  of	  forming	  chondro	  nodules	  under	  chondrogenesis	  differentiation	  conditions,	  however	  this	  did	  not	  occur	  under	  normal	  media	  conditions.	  The	  nodules	  were	  sectioned	  and	  then	  stained	  for	  cartilage	  deposition	  using	  alcain	  blue	  staining	  (Figure	  9E).	  TMSC	  2-­‐1	  was	  capable	  of	  differentiating	  into	  adipocytes	  under	  adipo	  media	  however	  did	  not	  differentiate	  into	  other	  mesenchymal	  lineages	  when	  subjected	  to	  differentiation	  conditions	  (Data	  not	  shown).	  These	  results	  demonstrated	  identification	  and	  isolation	  of	  a	  clonal	  cell	  (TMSC	  7-­‐10)	  from	  the	  thymus	  capable	  of	  differentiating	  into	  multiple	  mesenchymal	  lineages.	  	  
Maintenance	  in	  reaggregate	  with	  E15.5	  fetal	  thymic	  stroma.	  
	   After	  observing	  the	  multipotency	  of	  the	  TMSCs	  we	  tested	  the	  hypothesis	  the	  LRC	  that	  gave	  rise	  to	  TMSC	  maybe	  were	  capable	  of	  contributing	  to	  thymic	  epithelial	  microenvironment.	  As	  during	  thymic	  development	  we	  see	  transition	  of	  mesenchymal	  cells	  to	  epithelium	  cells	  in	  numerous	  tissues	  as	  well	  as	  a	  transition	  from	  epithelium	  to	  mesenchymal	  with	  age	  in	  thymus	  as	  well	  as	  other	  tissue	  [13,	  14,	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51].	  Hence	  we	  reasoned	  if	  these	  cells	  are	  stem	  cells	  of	  the	  thymus	  they	  should	  be	  able	  to	  contribute	  to	  the	  thymic	  microenvironment.	  
We	  isolated	  LRCs	  using	  FACS	  sorting	  to	  >95%	  purity	  from	  after	  6	  weeks	  of	  dox	  feeding.	  Simultaneously	  a	  partial	  depletion	  of	  TECs	  from	  dissociated	  thymic	  stroma	  derived	  from	  E15.5	  C57BL6	  fetal	  mice	  was	  preformed.	  As	  it	  has	  been	  previously	  shown	  that	  isolated	  fetal	  thymic	  stroma	  when	  placed	  as	  a	  standing	  drop	  of	  a	  cell	  slury	  on	  a	  transwell	  plate,	  has	  the	  ability	  to	  reaggregate	  and	  form	  a	  thymus	  which	  can	  then	  be	  transplanted	  under	  the	  kidney	  capsule	  of	  a	  nude	  mice	  and	  restores	  immunity	  in	  the	  nude	  mice	  [117].	  Sorted	  LRC	  removed	  from	  adult	  mice	  were	  transferred	  the	  partially	  EpCam	  depleted	  fetal	  stromal	  cell	  and	  transwell	  plate	  for	  2	  days.	  After	  2	  days	  we	  observed	  the	  formation	  of	  the	  reaggregate	  thymic	  tissue,	  which	  was	  subsequently	  surgically	  inserted	  under	  kidney	  capsule	  of	  a	  nude	  mice.	  After	  3	  weeks	  of	  in	  vivo	  growth,	  the	  mouse	  was	  euthanized	  and	  the	  kidney	  was	  isolated	  and	  prepped	  for	  cryostat	  sectioning.	  Dox	  was	  not	  fed	  to	  the	  nude	  mice	  and	  we	  expected	  H2BGFP	  expression	  to	  return	  to	  K5	  expressing	  cells	  that	  were	  derived	  from	  the	  adult	  LRCs.	  
We	  observed	  that	  the	  thymus	  grown	  on	  the	  kidney	  capsule	  had	  a	  normal	  distribution	  of	  cortical	  and	  medullary	  regions	  based	  on	  K5K8	  staining	  (Figure	  10A).	  LRCs	  had	  contributed	  to	  the	  reaggregate	  thymus	  in	  the	  medullary	  population	  of	  the	  reaggregate	  thymus	  depicted	  by	  K5	  and	  K14	  staining	  as	  well	  as	  the	  H2BGFP	  expression	  (Figure	  10B).	  	  Moreover	  the	  thymus	  also	  successfully	  at	  attracting	  early	  thymocyte	  progenitors	  that	  were	  undergoing	  differentiation	  depicted	  by	  CD4	  CD8	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staining	  (Figure	  10B	  lower	  panel	  &C)	  Furthermore	  double	  positive	  CD4CD8	  cells	  were	  found	  in	  the	  cortical	  regions	  (Yellow)	  and	  single	  positive	  cells	  were	  found	  in	  the	  medulla	  (Green	  and	  Red)	  (Figure	  10C).	  The	  LRCs	  also	  stained	  for	  immature	  mTEC	  marker	  K14	  along	  with	  cTEC	  marker	  DEC205	  (Figure	  10B).	  This	  result	  shows	  that	  LRCs	  can	  give	  rise	  to	  both	  cTEC	  and	  mTEC	  population.	  We	  were	  able	  to	  replicate	  these	  results	  twice	  out	  of	  twelve	  times,	  due	  to	  the	  low	  number	  of	  initial	  stem	  cells	  isolated	  from	  the	  lable	  retaining	  mice.	  However	  due	  to	  technical	  restrictions	  this	  experiment	  was	  difficult	  to	  replicate.	  Due	  to	  this	  limitation	  we	  utilized	  the	  FTOC	  technique	  with	  nude	  mice	  kidney	  capsule	  approach	  to	  further	  examine	  the	  capability	  of	  the	  TEC	  subset	  enriched	  in	  the	  LRCs	  that	  exhibited	  growth	  potential	  in-­‐vitro	  to	  contribute	  to	  thymic	  epithelial	  microenvironment	  
	   We	  isolated	  the	  two	  populations	  found	  with	  the	  LRCs	  including	  EpCAMloMHCIIloSca1+	  and	  MHCIIhiEpCAMhiSca1+	  thymic	  stromal	  subsets	  from	  C57BL6	  eGFP	  mice	  that	  express	  GFP	  ubiquitously	  in	  all	  cells.	  After	  sorting	  to	  >98%	  purity	  these	  GFP	  expressing	  cells	  were	  mixed	  with	  dissociated	  fetal	  stroma	  from	  E15.5	  C57BL6	  wild	  type	  mice	  together	  with	  a	  limited	  number	  of	  thymocytes	  and	  allowed	  them	  to	  form	  reaggregates	  over	  the	  next	  48	  hours	  on	  a	  polycarbonate	  filter	  supported	  on	  a	  transwell	  plate.	  The	  reaggregates	  were	  then	  imaged	  in	  phase	  and	  488nm	  excitation	  to	  observe	  eGFP	  in	  the	  reaggregate	  (Figure	  11A&B).	  It	  was	  observed	  that	  more	  GFP+	  cells	  were	  found	  in	  the	  reaggregate	  containing	  the	  EpCAMloMHCIIloSca1+	  subset	  than	  in	  reaggregate	  containing	  the	  MHCIIhiEpCAMhiSca1+subset	  (Figure	  11A&B).	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   The	  reaggregates	  were	  then	  surgically	  transplanted	  under	  the	  kidney	  capsule	  of	  nude	  mice.	  The	  kidneys	  were	  harvested	  3	  weeks	  post-­‐surgery	  and	  embedded,	  and	  cryostat	  sectioned.	  The	  sections	  were	  stained	  with	  anti-­‐GFP	  to	  detect	  adult	  cells	  that	  were	  maintained	  in	  the	  expanded	  thymic	  reaggregate.	  Initially	  we	  wanted	  to	  confirm	  that	  the	  thymic	  reaggregate	  that	  grew	  under	  kidney	  capsule	  were	  functional.	  In	  order	  to	  do	  so	  we	  stained	  the	  reaggregate	  thymus	  with	  anti-­‐CD4	  and	  anti-­‐CD8	  markers	  to	  confirm	  the	  presence	  of	  developing	  thymocytes.	  	  Subsequently	  we	  also	  used	  DAPI	  anti	  fade	  to	  preserve	  the	  staining	  as	  well	  as	  see	  cortical	  areas	  with	  a	  high	  density	  of	  cells	  and	  medullary	  areas	  with	  a	  lower	  density	  of	  cells.	  We	  observed	  the	  presence	  of	  abundant	  DP	  (purple)	  thymocytes	  in	  the	  cortical	  regions	  of	  the	  thymus	  as	  well	  as	  single	  positive	  CD4	  (red)	  and	  single	  positive	  CD8	  (blue)	  in	  the	  medullary	  region	  (Figure	  11C).	  	  These	  results	  confirmed	  the	  ability	  of	  the	  reaggregate	  thymus	  to	  attract	  T-­‐cell	  progenitors	  from	  the	  bone	  marrow	  and	  support	  the	  development	  of	  the	  mature	  single	  positive	  thymocytes.	  We	  also	  observed	  GFP	  expressing	  cells	  were	  located	  in	  both	  the	  cortex	  and	  the	  medulla	  when	  EpCAMloMHCIIloSca1+	  GFP	  expressing	  cells	  were	  used	  for	  the	  reaggregate	  (Figure	  11C,	  insert).	  	  
	   	  Even	  though	  there	  was	  not	  a	  dramatic	  expansion	  of	  GFP	  expressing	  adult	  cells	  in	  the	  reaggregate,	  staining	  with	  anti-­‐K8	  and	  UEA1	  revealed	  these	  adult	  cells	  had	  become	  part	  of	  the	  reaggregate	  thymus	  (Figure	  11D,	  arrows),	  as	  GFP	  expressing	  cells	  were	  positive	  for	  both	  K8	  (cTEC	  marker)	  and	  UEA1	  (mature	  mTECs).	  	  We	  further	  confirmed	  that	  these	  adult	  GFP	  positive	  cells	  had	  become	  a	  part	  of	  both	  the	  cTEC	  and	  mTEC	  population	  of	  the	  reaggregate	  using	  UEA1	  and	  anti-­‐DEC205	  (cTEC	  
33	  
marker)	  (Figure	  11E,	  arrows).	  Very	  limited	  numbers	  of	  GFP	  expressing	  cells	  were	  found	  in	  the	  reaggreagate	  thymus	  created	  use	  the	  MHCIIhiEpCAMhiSca1+	  subset	  reaggregate	  and	  those	  present	  did	  not	  incorporate	  into	  the	  TEC	  architecture	  and	  were	  mostly	  found	  in	  TEC	  free	  regions	  and	  blood	  vessels	  (Figure	  11F,	  insert).	  	  
Contribution	  of	  label	  retaining	  cells	  to	  thymic	  regeneration	  during	  transient	  thymic	  
involution	   	  
Adult	  stem	  cells	  are	  generally	  quiescent	  and	  only	  expand	  to	  produce	  progeny	  under	  conditions	  of	  demand	  in	  tissues.	  We	  reasoned	  that	  if	  LRCs	  were	  truly	  TEC	  progenitors	  that	  the	  demand	  caused	  by	  inducing	  transient	  thymic	  involution	  with	  Dexamethasone	  treatment	  would	  lead	  to	  a	  loss	  of	  H2BGFP	  label	  and	  differentiation	  of	  LRC	  to	  restore	  the	  thymic	  stroma.	  Since	  quiescent	  stem	  cell	  maintain	  the	  capability	  to	  proliferate	  under	  stress	  conditions	  [25].	  We	  treated	  6	  week	  dox	  fed	  K5tTA;TetO-­‐H2BGFP	  mice	  with	  50µL	  of	  dexamethasone	  at	  stock	  concentration	  of	  8mg/mL	  by	  intraperitoneal	  injection,	  as	  well	  as	  a	  control	  group	  injected	  with	  50uL	  of	  PBS.	  	  Dexamethasone	  is	  an	  anti-­‐inflammatory	  synthetic	  steroid	  from	  the	  glucocorticoid	  class,	  it	  is	  known	  to	  cause	  massive	  apoptosis	  in	  T-­‐cells	  and	  transiently	  degrade	  the	  thymic	  microenvironment	  [62].	  We	  followed	  the	  fate	  of	  the	  LRC	  in	  the	  thymus	  section	  at	  day	  5	  and	  day	  11	  after	  dex	  injection.	  Previous	  work	  had	  shown	  that	  the	  thymic	  recovery	  begins	  between	  day	  4	  and	  day	  6	  after	  dexamethasone	  (Dex)	  treatment	  and	  thymus	  is	  completely	  recovered	  around	  day	  10	  after	  treatment	  (Figure	  12).	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   At	  appropriate	  time	  points	  the	  thymuses	  were	  harvested,	  embedded	  and	  cryostat	  sectioned.	  The	  sections	  were	  then	  stained	  using	  Ki67	  to	  determine	  if	  the	  stem	  cells	  were	  undergoing	  proliferation.	  We	  observed	  that	  none	  of	  the	  LRCs	  were	  Ki67	  positive	  in	  the	  PBS	  injected	  mice	  and	  we	  had	  a	  limited	  number	  of	  LRCs	  in	  the	  tissue	  (Figure	  12A).	  However,	  the	  number	  of	  LRCs	  increased	  on	  day	  5	  and	  11	  after	  dex	  treatment,	  while	  the	  intensity	  of	  the	  H2BGFP	  decreased	  indicating	  that	  the	  LRCs	  were	  proliferating	  as	  they	  were	  also	  Ki67	  positive	  and	  contributing	  to	  the	  thymus	  during	  recovery	  (Figure	  12B&C).	  These	  cells	  were	  now	  found	  in	  both	  the	  thymic	  cortex	  and	  medulla,	  suggesting	  differentiation	  had	  taken	  place	  (Figure	  12B&C).	  After	  11	  days	  of	  Dex	  treatment	  there	  was	  a	  dramatic	  reduction	  in	  the	  numbers	  of	  LRCs	  suggesting	  the	  cells	  had	  proliferated	  and	  lost	  their	  label	  (Figure	  12C).	  Together	  these	  results	  demonstrate	  that	  LRCs	  undergo	  proliferation	  when	  Dex	  driven	  thymic	  involution	  and	  recovery	  takes	  place	  and	  suggesting	  that	  LRC	  cells	  may	  be	  playing	  an	  essential	  role	  in	  the	  thymic	  recovery	  and	  proving	  further	  evidence	  that	  the	  LRC	  subset	  contains	  a	  TEC	  progenitors/stem	  cell	  population.	  
Discussion	  	  	   Based	  on	  the	  quiescent	  state	  of	  stem	  cells,	  we	  set	  out	  to	  isolate	  a	  population	  of	  TECs	  with	  quiescent	  properties	  using	  a	  label	  retaining	  mouse	  model.	  The	  K5tTA;TetO-­‐H2BGFP	  tetracycline-­‐regulated	  transgenic	  mouse	  was	  utilized	  to	  localize	  and	  characterize	  the	  LRCs	  from	  the	  adult	  thymus	  using	  histology.	  These	  cells	  were	  later	  isolated	  using	  flow	  cytometry	  for	  characterization,	  clonal	  expansion,	  and	  differentiation.	  Before	  the	  mice	  were	  put	  on	  Dox	  feed,	  it	  was	  observed	  that	  all	  K5	  expressing	  TECs	  were	  H2BGFP	  labeled	  including	  the	  K5K8	  double	  positive	  TECs	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found	  at	  the	  Cortico-­‐medullary	  junction	  and	  thought	  to	  contain	  a	  progenitor	  population.	  After	  6	  to	  12	  weeks	  of	  Dox	  feeding	  there	  was	  a	  significant	  reduction	  in	  the	  number	  of	  H2BGFP	  expressing	  cells,	  which	  were	  primarily	  found	  within	  the	  medulla	  as	  well	  as	  the	  cortico-­‐medullary	  junction.	  Further	  analysis	  by	  histology	  relived	  that	  these	  cells	  expressed	  immature	  TEC	  markers	  like	  MTS10	  and	  K5	  or	  K5K8DP	  in	  addition	  most	  LRCs	  expressed	  keratinocyte	  stem	  cell	  marker	  ΔNP63[47].	  ΔNP63	  is	  expressed	  within	  all	  immature	  TECs	  in	  thymus	  and	  loss	  of	  P63	  expression	  results	  in	  a	  hypoplastic	  thymus	  [48].	  However,	  it	  is	  not	  a	  marker	  for	  stem	  cells	  in	  the	  thymus	  but	  is	  believed	  to	  contain	  a	  certain	  subset	  of	  cells	  with	  stem	  cell	  potential.	  H2BGFPdim	  cells	  were	  also	  observed	  in	  Keratin-­‐negative	  cells,	  suggesting	  epithelial	  to	  mesenchymal	  transition	  may	  be	  occurring.	  This	  is	  significant	  because	  they	  may	  still	  retain	  their	  ability	  to	  undergo	  mesenchymal	  to	  epithelial	  transition	  to	  repair	  the	  thymus	  under	  demand,	  as	  we	  have	  observed	  a	  decrease	  in	  fat	  tissue	  surrounding	  the	  thymus	  in	  old	  male	  mice	  when	  the	  thymus	  undergoes	  transient	  recovery	  due	  to	  castration	  (Data	  not	  shown).	  
	   We	  confirmed	  using	  FACS	  the	  presence	  of	  a	  high	  number	  of	  H2BGFPdim	  cells	  after	  ten	  weeks	  on	  dox	  feed	  as	  well	  as	  a	  small	  number	  of	  H2BGFPbright	  cells.	  We	  further	  separated	  the	  cells	  using	  EpCAM	  and	  MHCII	  expression,	  which	  defines	  TEC	  populations.	  	  The	  LRCs	  were	  primarily	  observed	  in	  two	  populations,	  the	  EpCAMhiMHCint	  and	  EpCAMloMHCIIlo	  subsets.	  The	  H2BGFPhi	  cells	  were	  primarily	  observed	  in	  EpCAMhiMHCint	  TEC	  subset	  whereas	  the	  H2BGFPdim	  were	  primarily	  in	  EpCAMloMHCIIlo	  TEC	  subsets.	  Subsequently	  we	  tested	  the	  growth	  potential	  of	  LRCs	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in	  vitro	  and	  observed	  only	  EpCAM+	  LRCs	  grew	  in	  culture	  and	  EpCAM+	  non-­‐LRCs	  did	  not.	  	  
	   Initially	  these	  cells	  maintained	  their	  K5	  driven-­‐H2BGFP	  expression	  in	  culture.	  This	  initial	  maintenance	  of	  label	  confirms	  these	  cells	  were	  derived	  from	  K5	  expressing	  TECs	  (Figure	  2,3&6).	  	  Cell	  surface	  analysis	  of	  the	  in	  vitro	  expanded	  clonal	  LRCs	  revealed	  that	  these	  cells	  were	  virtually	  identical	  to	  MSCs	  while	  in	  culture	  except	  for	  EpCAM	  and	  MHCII,	  markers	  used	  to	  identify	  these	  thymic	  derived	  cells	  (Figure	  8).	  Subsequently,	  differentiation	  assays	  performed	  on	  the	  cultured	  clonal	  cells	  confirmed	  that	  they	  could	  differentiate	  into	  multiple	  lineages	  including	  osteoblasts,	  adipocytes	  and	  chondrocytes	  (Figure	  9).	  We	  also	  demonstrated	  the	  ability	  of	  sorted	  LRCs	  to	  become	  a	  part	  of	  the	  thymic	  microenvironment	  and	  be	  maintained	  as	  mTECs	  and	  cTECs	  using	  partially	  TEC	  depleted	  fetal	  thymic	  reaggregates	  mixed	  with	  the	  LRCs	  (Figure	  10&11).	  	  LRCs	  also	  appeared	  to	  contribute	  to	  reconstitution	  of	  the	  thymus	  when	  put	  under	  demand	  in	  a	  dex	  induced	  transient	  thymic	  involution	  assay.	  It	  was	  observed	  that	  LRCs	  depleted	  their	  label	  as	  the	  thymus	  recovers	  from	  dexamethasone	  driven	  involution	  and	  expanded	  in	  both	  numbers	  and	  location	  (Figure	  12).	  	  
	   The	  markers	  for	  stem	  cells	  as	  well	  as	  MSCs	  utilized	  in	  the	  study	  are	  remarkably	  conserved	  as	  a	  cell	  surface	  markers	  irrespective	  of	  their	  origin.	  Sca1	  had	  been	  shown	  to	  be	  expressed	  on	  hematopoietic,	  prostate,	  lung,	  cardiac	  and	  mammary	  stem	  cells,	  along	  with	  other	  MSCs	  isolated	  from	  several	  sources	  [31,	  54,	  57,	  63-­‐65].	  Similarly,	  alpha6	  intergrin/CD49F	  has	  also	  been	  identified	  in	  several	  stem	  cell	  types	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specifically	  when	  co-­‐expressed	  with	  intergrin	  beta1/CD29.	  Isolation	  and	  enrichment	  of	  skin	  stem	  cells	  was	  achieved	  by	  sorting	  of	  the	  CD49FhiCD29hi	  population	  [66,	  67].	  Both	  mammary	  as	  well	  as	  prostate	  stem	  cells	  were	  observed	  to	  have	  a	  Sca1loCD49FhiCD29hi	  surface	  phenotype	  [65,	  68].	  Furthermore	  CD49F	  has	  been	  shown	  to	  be	  consistently	  overexpressed	  in	  hematopoietic	  and	  embryonic	  stem	  cells	  [69].	  In	  conjunction	  with	  these	  markers	  it	  was	  also	  observed	  that	  mesencymal	  stem	  cells	  isolated	  from	  variety	  of	  tissues	  also	  expressed	  CD44	  [31,	  70,	  71].	  
Using	  these	  markers	  we	  identified	  the	  cell	  surface	  phenotype	  of	  the	  LRCs	  from	  the	  thymus.	  These	  cells	  were	  EpCAMloMHCIIlo/negSca1hiCD49FloCD29+.	  Multiple	  clonal	  lines	  were	  derived	  from	  this	  population	  of	  cells	  from	  wild	  type	  mice	  up	  to	  eight	  month	  of	  age.	  We	  further	  analyzed	  these	  cells	  using	  FACS	  and	  observed	  that	  compared	  to	  the	  wild	  type	  mice	  the	  LRCs	  in	  K5tTA;TetO-­‐H2BGFP	  mice	  were	  primarily	  only	  Sca1hi	  whereas	  the	  cells	  in	  the	  wild	  type	  mice	  were	  both	  Sca1hi	  and	  Sca1lo	  (Figure	  4	  B&G).	  Additionally	  we	  analyzed	  the	  Sca1hi	  and	  Sca1lo	  subset	  of	  population	  from	  the	  wild	  type	  mice	  for	  CD49F	  and	  CD29.	  It	  was	  observed	  that	  only	  Sca1hi	  population	  contained	  a	  CD49FloCD29hi	  subset	  which	  exhibited	  in	  vitro	  growth	  potential	  and	  the	  ability	  to	  differentiate	  into	  multiple	  mesencymal	  lineages.	  
While	  the	  capacity	  for	  label	  retention	  was	  not	  adequate	  to	  absolutely	  identify	  the	  thymic	  stem	  cell	  population,	  it	  did	  prove	  to	  be	  a	  useful	  tool	  for	  enrichment	  of	  the	  thymic	  stroma	  with	  stem	  cell	  properties.	  These	  results	  demonstrated	  the	  presence	  of	  postnatal	  thymic	  population	  capable	  of	  pluripotentcy	  (Figure	  9).	  	  Tissue-­‐restricted	  gene	  expression	  is	  needed	  for	  deletion	  of	  self-­‐reactive	  T	  cells	  that	  could	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mount	  autoimmune	  response.	  A	  transcription	  factor	  that	  drives	  tissue-­‐restricted	  gene	  expression	  is	  Aire	  [12].	  Hence	  Aire	  can	  be	  used	  as	  a	  terminally	  differentiation	  marker	  in	  TECs	  population.	  None	  of	  the	  LRCs	  expressed	  Aire	  in	  IHC	  (Figure	  2)	  or	  in	  reverse	  transcriptase	  PCR	  of	  non-­‐clonal	  cell	  lines	  (data	  not	  shown).	  	  
Thymic	  epithelium	  has	  been	  shown	  to	  arise	  from	  third	  pharyngeal	  pouch	  endoderm	  [72].	  Epithelial	  cells	  are	  normally	  distinguished	  using	  the	  cytokeratins	  along	  with	  cell	  polarity	  and	  strong	  intercellular	  connections.	  Mesenchymal	  cells	  however	  lack	  distinct	  intercellular	  connections	  and	  express	  vimentin	  intermediate	  filaments	  [73].	  	  TECs	  can	  be	  further	  defined	  by	  EpCAM	  expression	  as	  well	  as	  expression	  of	  a	  variety	  of	  keratins.	  MSCs	  do	  not	  typically	  express	  EpCAM	  or	  other	  epithelial	  specific	  molecules	  including	  keratins	  or	  E-­‐cadherin,	  however	  these	  two	  cell	  types	  are	  known	  to	  share	  reciprocal	  plasticity.	  This	  plasticity	  is	  seen	  in	  tumor	  progression,	  tissue	  repair,	  and	  embryonic	  morphogenesis	  by	  epithelial	  to	  mesenchymal	  transition	  (EMT)	  as	  well	  as	  mesenchymal	  to	  epithelial	  transition	  (MET)[73].	  Hence	  these	  thymic	  mesenchymal	  stem	  cells	  have	  the	  same	  surface	  phenotype	  as	  the	  LRCs	  in	  the	  thymus	  that	  become	  active	  under	  demand	  conditions.	  Suggesting	  these	  mesenchymal	  cells	  may	  still	  retain	  the	  ability	  to	  transition	  into	  epithelium	  under	  suitable	  conditions.	  	  	  	  
EMT	  followed	  by	  mesenchymal	  cell	  differentiation	  into	  FAT	  cells	  has	  been	  previously	  described	  in	  the	  thymus	  as	  a	  result	  of	  thymic	  aging	  and	  is	  also	  observed	  in	  our	  culture	  conditions	  after	  high	  passage	  cells	  are	  left	  under	  confluent	  conditions[13,	  14,	  51].	  	  This	  may	  also	  help	  explain	  why	  TECs	  isolated	  from	  the	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thymus	  become	  TMSCs	  under	  culture	  conditions;	  long	  term	  growth	  of	  these	  cells	  leads	  to	  a	  complete	  loss	  of	  EpCAM,	  FOXN1,	  and	  MHCII	  expression	  (Figure	  9).	  Our	  results	  suggest	  EMT	  that	  is	  occurring	  in	  the	  thymus	  as	  a	  part	  of	  age	  related	  involution	  may	  lead	  to	  the	  production	  of	  multipotent	  mesenchymal	  stem	  cell	  or	  changes	  in	  morphology	  that	  we	  observe	  may	  imitate	  an	  inherent	  pluripotency	  of	  TECs	  coupled	  with	  the	  absents	  of	  the	  thymic	  microenvironment	  in	  the	  culture	  conditions.	  However,	  recent	  studies	  have	  demonstrated	  the	  abilities	  of	  TEC	  cell	  lines	  from	  rat	  fetus	  and	  newborn	  to	  differentiate	  into	  skin	  epithelium	  under	  a	  wound-­‐healing	  assay	  [74].	  	  This	  indicates	  that	  the	  microenvironment	  dictates	  and	  provides	  signals	  that	  cause	  changes	  in	  the	  epithelial	  cells	  fate	  and	  allowing	  them	  to	  redirect	  into	  other	  (skin)	  epithelial	  based	  tissue	  on	  demand.	  	  Hence	  further	  suggesting	  that	  the	  TMSCs	  described	  here	  may	  be	  mesencymal	  in	  nature	  due	  to	  the	  in	  vitro	  culture	  environment	  and	  that	  subjecting	  them	  to	  the	  in	  vivo	  thymic	  microenvironment	  may	  revert	  them	  back	  to	  TECs.	  	  
MSCs	  isolated	  from	  several	  sources	  have	  shown	  the	  capability	  of	  differentiating	  into	  mesodermal	  cell	  types	  including	  chondrocytes,	  osteoblasts,	  adipocytes	  and	  myocytes	  in	  the	  presence	  of	  selective	  growth	  media[31,	  75-­‐79].	  Remarkably	  MSCs	  have	  also	  been	  shown	  to	  differentiate	  into	  both	  ectodermal	  and	  endodermal	  tissue	  including	  neural	  cells,	  hepatocytes,	  pancreatic	  islet	  cells,	  endothelial	  cells	  and	  epithelial	  cells[80-­‐89].	  Future	  efforts	  will	  examine	  the	  ability	  of	  TMSCs	  to	  differentiate	  into	  TECs	  under	  conditions	  of	  demand.	  The	  study	  will	  follow	  wild	  type	  Dex	  injected	  mice	  that	  receive	  tail	  vein	  or	  intra	  thymic	  injection	  of	  TMSCs	  that	  have	  been	  GFP	  tagged,	  to	  see	  if	  these	  cells	  home	  back	  to	  the	  thymus	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Figure	  1.Mouse	  model	  of	  label	  retention.	  
Figure	  2.	  Changes	  in	  H2BGFP	  expression	  within	  TECs	  in	  K5tTA;TetO-­‐H2BGFP	  transgenic	  mice	  following	  a	  time	  course	  of	  Dox	  feeding	  	  
A.	  Thymic	  sections	  prepared	  at	  the	  initiation	  of	  Dox	  feeding	  and	  from	  2-­‐6	  weeks	  after	  the	  start	  of	  Dox	  feeding	  showing	  the	  reduction	  in	  H2BGFP	  expressing	  TECs.	  	  Sections	  were	  stained	  with	  anti-­‐K8	  (red)	  and	  anti-­‐K5	  antibodies	  (blue)	  to	  allow	  localization	  of	  the	  H2BGFP	  expressing	  nuclei	  within	  TECs.	  	  B.	  	  Representative	  FACS	  analysis	  of	  CD45-­‐	  dissociated	  thymic	  stroma	  showing	  the	  frequency	  of	  EpCAM+	  H2BGFP+	  cells	  at	  time	  0,	  2,	  4	  and	  6	  weeks	  after	  the	  initiation	  of	  Dox	  feeding	  to	  inhibit	  H2BGFP	  expression	  in	  K5+TECs.	  	  Gates	  from	  left	  to	  right	  in	  each	  panel	  show	  the	  frequency	  of	  EpCAM+H2BGFP-­‐,	  EpCAM+H2BGFPlo	  and	  EpCAM+GFPhi	  TECs	  at	  each	  time	  point.	  	  C.	  	  Graph	  shows	  the	  mean	  number	  of	  EpCAM+H2BGFPhi	  label-­‐retaining	  cells	  and	  the	  number	  of	  EpCAM+H2BGFPlo	  cycling	  cells	  per	  thymus	  at	  0,	  2,	  4,	  6	  and	  12	  weeks	  after	  the	  inhibition	  of	  H2BGFP	  expression	  through	  Dox	  feeding.	  	  Error	  bars	  are	  +/-­‐	  the	  standard	  deviation	  of	  the	  mean.	  	  Results	  are	  representative	  of	  3	  independent	  experiments	  with	  5	  mice	  at	  each	  time	  point/experiment.	  	  D.	  	  Graph	  depicts	  the	  mean	  number	  of	  CD45-­‐	  EpCAM+	  TECs/thymus	  at	  0,	  2,	  4,	  6	  and	  12	  weeks	  after	  the	  inhibition	  of	  H2BGFP	  expression	  through	  Dox	  feeding.	  	  Error	  bars	  are	  +/-­‐	  the	  standard	  deviation	  of	  the	  mean.	  
	  
42	  
Figure	  3.	  Localization	  and	  characterization	  of	  thymic	  label-­‐retaining	  cells	  in	  K5tTA;TetO-­‐H2BGFP	  mice	  
A.	  	  H2BGFP	  expression	  in	  thymic	  section	  prior	  to	  Dox	  feeding	  (100X).	  B.	  H2BGFP	  expression	  in	  thymic	  section	  after	  10-­‐week	  Dox	  feeding.	  C.	  Overlay	  of	  H2BGFP	  (green),	  K8	  (red)	  and	  K5	  (blue)	  expression	  prior	  to	  Dox	  feeding.	  	  White	  arrows	  show	  H2BGFP	  LRCs	  concentrated	  at	  cortico-­‐medullary	  junction	  defined	  by	  K5	  and	  K8	  staining	  (inset=	  K5,	  H2BGFP	  overlay	  400X	  showing	  that	  H2BGFP	  is	  restricted	  to	  K5-­‐expressing	  cells).	  D.	  Overlay	  of	  H2BGFP,	  K8	  and	  K5	  in	  thymic	  section	  following	  10-­‐week	  Dox	  chase	  (inset:	  400X	  of	  H2BGFP	  LRCs	  stained	  with	  K5	  and	  K8	  at	  CMJ).	  	  	  E.	  400x	  images	  of	  thymic	  sections	  showing	  expression	  of	  MTS10,	  H2BGFP,	  Ki67	  and	  merge.	  	  White	  arrows	  define	  position	  of	  H2BGFPhi	  LRCs.	  	  F.	  400X	  images	  of	  thymic	  sections	  showing	  expression	  of	  ΔNP63,	  H2BGFP,	  Aire	  and	  merge.	  	  White	  arrows	  define	  position	  of	  H2BGFPhi	  LRCs.	  G	  400x	  images	  of	  thymic	  sections	  showing	  staining	  with	  UEA1	  PE	  (red)	  and	  DEC	  205	  Alexa	  647	  (pink)	  together	  with	  H2BGFP	  and	  Merge.	  	  H.	  400x	  images	  of	  thymic	  sections	  derived	  from	  K5tTA;tetO-­‐H2BGFP	  mice	  prior	  to	  Dox	  feeding	  stained	  with	  UEA1PE	  (red)	  and	  DEC205	  Alexa	  647(Pink)	  together	  with	  H2BGFP	  and	  merge.	  
	  
Figure	  4.	  Cell	  Surface	  Profile	  of	  H2BGFP	  LRCs	  
A.	  Gating	  strategy	  for	  analysis	  of	  LRCs	  based	  on	  EpCAM	  and	  H2BGFP	  expression	  during	  0-­‐6	  week	  Dox	  feeding	  time	  course.	  Gate	  frequencies	  from	  left	  to	  right	  show	  total	  H2BGFP+,	  H2BGFPlo	  and	  H2BGFPhi,	  respectively.	  	  B.	  Characterization	  of	  changes	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EpCAM	  and	  MHCII	  expression	  in	  total	  CD45-­‐	  stroma,	  total	  GFP+,	  GFPlow	  and	  GFPhi	  subsets,	  every	  2	  weeks	  during	  a	  6-­‐week	  Dox	  time	  course.	  	  
	  
Figure	  5.	  LRCs	  become	  progressively	  enriched	  in	  Sca1+TECs	  and	  contain	  a	  unique	  subset	  of	  MHCIIloEpCAMloSca1+CD49FloCD29+	  cells.	  	  
A.	  Gating	  strategy	  for	  analysis	  of	  TEC	  subsets	  defined	  by	  MHCII	  and	  EpCAM	  expression	  in	  C57BL/6J	  dissociated	  thymic	  tissue.	  B.	  Sca1	  expression	  within	  the	  3	  subsets	  defined	  by	  MHCII	  and	  EpCAM	  expression.	  C.	  	  Characterization	  of	  CD49F	  and	  CD29	  expression	  within	  the	  Sca1+	  TECs	  defined	  by	  MHCII	  and	  EpCAM	  expression.	  	  The	  MHCIIloEpCAMlo	  Sca1+	  TECs	  contain	  a	  unique	  CD49FloCD29+	  subset	  not	  found	  in	  other	  populations	  defined	  by	  MHCII	  and	  EpCAM	  expression	  or	  within	  Sca1-­‐	  TEC	  subsets.	  D.	  Characterization	  of	  CD49F	  and	  CD29	  expression	  within	  the	  Sca1-­‐	  TECs	  defined	  by	  MHCII	  and	  EpCAM	  expression.E.	  Sca1	  expression	  within	  the	  subsets	  of	  LRCs	  during	  an	  8-­‐week	  Dox	  time	  course.	  	  F.	  Characterization	  of	  EpCAM+	  LRCs	  following	  10-­‐week	  Dox	  feeding.	  	  Upper	  panel	  shows	  gating	  used	  to	  define	  H2BGFPhi	  and	  H2BGFPlo	  subsets	  of	  LRCs.	  	  Middle	  3	  panels	  show	  characterization	  of	  total	  EpCAM+	  as	  well	  as	  H2BGFPlo	  and	  H2BGFPhi	  LRCs	  using	  BP1	  to	  define	  cTECs	  and	  UEA1	  to	  define	  mTECs.	  	  Lower	  3	  panels	  show	  expression	  of	  MHCII	  and	  EpCAM	  in	  the	  same	  3	  populations.	  	  G.	  H2BGFP+	  LRCs	  were	  separated	  into	  MHCIIloEpCAMhi	  and	  MHCIIlo/-­‐	  EPCAMlo	  subsets	  and	  then	  analyzed	  for	  Sca1	  expression	  (upper	  row).	  	  Sca1+	  cells	  in	  each	  population	  were	  then	  analyzed	  for	  CD29	  and	  CD49F.	  	  Results	  were	  representative	  of	  5	  independent	  experiments.	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Figure	  6.	  In	  vitro	  growth	  potential	  of	  H2BGFP	  LRCs.	  
Methylene	  blue	  stained	  colonies	  derived	  from	  FACS	  sorted	  CD45-­‐	  EpCAMlo	  MHCIIlo/-­‐Sca1+H2BGFP+	  LRCs	  (A)	  or	  CD45-­‐MHCIIintEpCAMhi	  Sca1+	  H2BGFP+	  stroma	  (B).	  C.	  Merge	  of	  H2BGFP	  expression	  and	  phase	  contrast	  image	  of	  expanded	  EpCAMloMHCIIlo/-­‐	  H2BGFP+	  LRCs	  1	  week	  after	  sorting,	  demonstrating	  dramatic	  in	  
vitro	  growth.	  	  D.	  Merge	  of	  H2BGFP	  expression	  and	  phase	  contrast	  image	  showing	  limited	  expansion	  of	  EpCAMhi	  MHCIIintH2BGFP+	  LRCs	  1	  week	  after	  sorting.	  E.	  H2BGFP	  expression	  in	  same	  field	  as	  C.	  F.	  H2BGFP	  expression	  in	  same	  field	  as	  D.	  These	  results	  are	  representative	  of	  3	  independent	  experiments	  performed	  with	  10-­‐12	  week	  Dox	  fed	  H2BGFP	  mice.	  	  Methylene	  blue	  stained	  colonies	  derived	  from	  FACS	  sorted	  CD45-­‐MHCIIlo/-­‐EpCAMlo	  Sca1+CD49Flo	  CD29+	  (G)	  or	  CD45-­‐MHCIIintEpCAMhiSca1+CD49FhiCD29+	  stroma	  (H)	  derived	  from	  WT	  C57BL/6J	  mice.	  	  I.	  	  Colony	  forming	  potential	  of	  sorted	  LRCs	  and	  defined	  TEC	  subsets	  sorted	  from	  dissociated	  thymus	  derived	  from	  postnatal	  C57BL/6J	  mice.	  	  Error	  bars	  show	  standard	  deviation	  of	  means	  calculated	  from	  5	  independent	  experiments.	  	  P	  values	  are	  derived	  by	  comparison	  of	  colony	  forming	  potential	  of	  sets	  of	  populations	  using	  T	  test.	  
	  
Figure	  7.	  Morphology	  of	  TMSC	  lines	  in	  culture.	  
A.	  Phase	  image	  of	  TMSC7-­‐10	  at	  P3;	  B.	  Phase	  image	  of	  TMSC2-­‐1at	  P12	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Figure	  8.	  Gene	  Expression	  Profile	  of	  clonal	  TMSC	  lines	  
A.	  Clonal	  TMSC	  lines	  exhibit	  a	  surface	  profile	  similar	  to	  mesenchymal	  stem	  cells.	  Cell	  surface	  profile	  of	  TMSC7-­‐10	  and	  TMSC2-­‐1	  cell	  lines	  after	  10	  passages.	  For	  each	  antibody	  overlay,	  the	  grey	  filled	  histogram	  shows	  isotype	  control	  antibody	  staining	  and	  the	  solid	  and	  dotted	  black	  histograms	  shows	  staining	  with	  the	  specific	  antibody	  for	  the	  TMSC7-­‐10	  and	  TMSC2-­‐1	  cell	  lines,	  respectively.	  B.	  Comparison	  of	  Gene	  expression	  in	  sorted	  TEC	  subsets	  and	  TMSC7-­‐10	  at	  P16.	  	  Total	  RNA	  was	  isolated	  from	  TEC	  subsets	  sorted	  to	  >95%	  purity	  together	  with	  the	  clonal	  TMSC7-­‐10	  cell	  line.	  	  Quantitative	  PCR	  was	  then	  performed	  using	  a	  Taqman	  assay	  for	  the	  TEC	  specific	  markers	  Foxn1	  and	  EpCAM	  as	  well	  as	  the	  stem	  cell	  markers	  Nanog,	  Oct4	  and	  Sox2.	  	  All	  results	  were	  normalized	  to	  18SrRNA	  and	  compared	  to	  the	  MHCIIint	  EpCAMhi	  TEC	  subset	  using	  the	  ΔΔCt	  method.	  	  
	  
Figure	  9.	  Clonal	  TMSC	  lines	  maintain	  the	  capacity	  to	  form	  Adipocytes,	  Osteoblasts	  and	  Chondrocytes	  in	  vitro	  
A.	  TMSC7	  cell	  line	  cultured	  in	  MEMa	  medium	  supplemented	  with	  EGF,	  FGF	  and	  LIF	  and	  then	  stained	  with	  Oil	  Red	  O;	  B.	  Oil	  Red	  S	  staining	  of	  TMSC7	  cultured	  in	  KSFM	  +	  10%	  FBS	  +	  EGF	  which	  induced	  adipogenesis	  (inset	  400X	  image	  of	  Oil	  Red	  O	  staining	  droplets	  of	  lipid);	  C.	  Alizarin	  Red	  S	  staining	  of	  TMSC7	  cultured	  in	  control	  medium;	  D.	  Alizarin	  Red	  S	  staining	  of	  mineral	  deposits	  in	  TMSC7	  cultured	  in	  osteogenesis	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differentiation	  medium;	  E.	  Alcian	  Blue	  staining	  of	  frozen	  section	  of	  Chondro-­‐nodule	  following	  culture	  of	  TMSC7	  cultured	  in	  chondrogenesis	  conditions.	  (Mag.	  A	  -­‐	  D,	  100X;	  inset	  and	  E	  400X)	  Similar	  results	  for	  all	  differentiation	  assays	  were	  obtained	  in	  a	  minimum	  of	  3	  experiments	  and	  with	  multiple	  TMSC	  lines.	  
	  
Figure	  10.	  Label	  Retaining	  Cells	  from	  the	  Thymus	  contain	  adult	  stem	  cells	  capable	  of	  reforming	  Thymic	  tissue.	  	  
A.	  Normal	  cortical	  and	  medullary	  thymic	  structure	  is	  observed	  after	  3	  weeks	  of	  growth	  under	  the	  kidney	  capsule	  based	  on	  Keratin	  5	  and	  Keratin	  8	  staining.	  B.	  High	  magnification	  images	  of	  reaggregate	  thymus	  stained	  with	  the	  mTEC	  markers	  K14	  or	  K5	  as	  well	  as	  cTEC	  markers	  DEC205	  or	  K8	  together	  with	  H2BGFP	  revealed	  abundant	  H2BGFP	  expressing	  TECs	  in	  both	  cortex	  and	  medulla	  that	  could	  only	  be	  derived	  from	  the	  sorted	  LRCs.	  C.	  Thymus	  recruited	  T	  cell	  progenitors	  and	  developed	  into	  CD4CD8DP	  cells,	  as	  well	  as	  mature	  CD4	  and	  CD8	  SP	  T	  cells	  showing	  that	  the	  reggregate	  thymus	  was	  functional.	  	  
	  
Figure	  11.	  Sorted	  EpCAMlo	  MHCIIlo	  Sca1+	  TECs	  contribute	  to	  thymic	  reaggregates	  after	  transplant	  under	  the	  nude	  mouse	  kidney	  capsule	  
A.	  	  40x	  phase	  and	  GFP	  fluorescence	  images	  of	  a	  reaggregate	  thymus	  created	  from	  sorted	  EpCAMloMHCIIloSca1+	  TEC	  derived	  from	  B6eGFP	  mice	  mixed	  with	  dissociated	  B6	  E15.5	  fetal	  thymus.	  	  B.	  40x	  phase	  (left)	  and	  GFP	  fluorescence	  images	  (right)	  of	  a	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reaggregate	  thymus	  created	  from	  sorted	  EpCAMlhiMHCIIhiSca1+	  TEC	  derived	  from	  B6eGFP	  mice	  mixed	  with	  dissociated	  B6	  E15.5	  fetal	  thymus.	  C.	  200X	  confocal	  fluorescence	  images	  of	  a	  10μm	  frozen	  section	  prepared	  an	  EpCAMloMHCIIloSca1+	  reaggregate	  thymus	  under	  the	  kidney	  capsule	  of	  a	  nude	  mouse	  stained	  with	  DAPI	  (left)	  and	  anti	  CD4PE	  (red),	  anti-­‐CD8APC	  (blue)	  and	  anti-­‐GFP	  FITC	  (green).	  	  The	  kidney	  is	  clearly	  visible	  on	  the	  lower	  right	  of	  each	  panel.	  	  D.	  Localization	  of	  sorted	  EpCAMlo	  MHCIIlo	  Sca1+	  GFP+	  cells	  retained	  in	  sections	  of	  reaggregate	  thymus	  grown	  under	  nude	  mouse	  kidney	  capsule	  for	  3	  weeks.	  	  	  Arrows	  indicate	  the	  location	  of	  GFP+	  cells	  in	  each	  panel.	  	  Sections	  were	  stained	  with	  anti	  Keratin	  8-­‐PE	  (red),	  antiGFP-­‐FITC	  (green),	  UEA1	  APC	  (pink)	  and	  DAPI	  (blue).	  	  Upper	  5	  cells	  were	  K8+UEA1+	  while	  lower	  3	  only	  expressed	  K8.	  	  E.	  Sections	  of	  reaggregates	  containing	  EpCAMloMHCIIloSca1+	  adult	  TECs	  stained	  with	  UEA1PE	  (red),	  Anti-­‐GFP	  FITC	  (green)	  DEC205	  Alexa647	  (pink)	  and	  DAPI	  (blue).	  	  In	  the	  last	  merged	  panel	  GFP+	  adult	  cells	  included	  UEA1+	  and	  UEA1-­‐	  mTECs,	  as	  well	  DEC205+	  cTECs.	  F.	  Localization	  of	  sorted	  EpCAMhi	  MHCIIhi	  Sca1+	  GFP+	  cells	  retained	  in	  sections	  of	  reaggregate	  thymus	  grown	  under	  nude	  mouse	  kidney	  capsule	  for	  3	  weeks.	  	  	  Arrows	  indicate	  the	  location	  of	  GFP+	  cells	  in	  each	  panel.	  	  Sections	  were	  stained	  with	  anti	  Keratin	  8-­‐PE	  (red),	  antiGFP-­‐FITC	  (green),	  UEA1	  APC	  (pink)	  and	  DAPI	  (blue).	  	  White	  C=	  cortex,	  White	  M=	  medulla	  in	  all	  panels.	  
Figure	  12.	  Dexamethasone	  driven	  involution	  of	  LRmice.	  
Age	  matched,	  sex	  matched	  LRmice	  were	  injected	  with	  50uL	  of	  8mg/mL	  stock	  concentration	  of	  dexamethasone.	  All	  mice	  were	  on	  6	  week	  dox	  food	  diet.	  Label	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retention	  was	  observed	  at	  day	  5	  and	  11	  after	  dex	  driven	  involution.	  A.	  PBS	  injected	  control	  on	  6	  weeks	  of	  dox	  feed.	  LRCs	  (Green)	  were	  found	  not	  stained	  with	  Ki67	  (Blue).	  B.	  Day	  5	  post	  dex	  a	  significant	  increase	  in	  LRCs	  was	  observed,	  some	  LRCs	  also	  stained	  positive	  for	  Ki67.	  C.	  Day	  11	  post	  dex	  treatment	  resulted	  in	  significant	  decrease	  in	  LRCs.	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